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Medical Marijuana in Public Schools: A Narrative Study of Parents’ Experiences 
with Policy Implementation 
Abstract 
Parents of children with conditions such as epilepsy, cancer, and attention deficit hyperactivity disorder 
(ADHD) can choose medical marijuana (MM) as a treatment plan for their children. The purpose of this 
narrative study is to describe parents’ experiences when implementing medical marijuana treatment 
plans in K-12 schools in New Jersey, Maryland, and Colorado. This study addressed the success and 
challenges parents faced with the chosen treatment plan. Many schools grapple with allowing the 
administration of MM to students because of the conflict between federal and state laws. This study 
identifies the experiences of parents of children prescribed MM as they navigate their chosen treatment 
plan. This study highlights the positive experiences they have encountered and identifies the barriers 
parents faced in the implementation of their plans. This study describes the reasons for the selection of a 
MM treatment plan, the legislation required to implement a school board policy, and the importance of a 
network of parents who served as a resource to assist with the implementation policy of MM in their 
child’s schools. The data derived from personal interviews with five parents who chose medical marijuana 
for their children’s treatment plans. The data identified themes of unsuccessful outcomes with 
pharmaceutical medicines, parents learning from other parents, school performance, in addition to 
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Parents of children with conditions such as epilepsy, cancer, and attention deficit 
hyperactivity disorder (ADHD) can choose medical marijuana (MM) as a treatment plan 
for their children. The purpose of this narrative study is to describe parents’ experiences 
when implementing medical marijuana treatment plans in K-12 schools in New Jersey, 
Maryland, and Colorado. This study addressed the success and challenges parents faced 
with the chosen treatment plan. Many schools grapple with allowing the administration of 
MM to students because of the conflict between federal and state laws. This study 
identifies the experiences of parents of children prescribed MM as they navigate their 
chosen treatment plan.  This study highlights the positive experiences they have 
encountered and identifies the barriers parents faced in the implementation of their plans. 
This study describes the reasons for the selection of a MM treatment plan, the legislation 
required to implement a school board policy, and the importance of a network of parents 
who served as a resource to assist with the implementation policy of MM in their child’s 
schools. 
The data derived from personal interviews with five parents who chose medical 
marijuana for their children’s treatment plans. The data identified themes of unsuccessful 
outcomes with pharmaceutical medicines, parents learning from other parents, school 
performance, in addition to benefits and challenges of MM policy. 
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Chapter 1: Introduction 
Parents of students diagnosed with medical conditions such as attention deficit 
hyperactivity disorder and epilepsy are seeking medical marijuana as a treatment option 
(Ryan et al., 2020) Their choice to have medical marijuana administered in public 
schools has created difficulties for state and federal lawmakers, students, school districts, 
and parents/guardians (Terrell, 2016). Thompson (2015) posited that medical marijuana 
benefits the lives of many people who suffer from life changing illnesses, such as 
multiple sclerosis (MS), epilepsy, autism, and glaucoma. In most cases, medical 
marijuana is prescribed and used in the form of a plant and in an oil (cannabis oil), that 
the patient can ingest either through food or drink. While medical marijuana has been 
legal in some states for almost two decades, it is still illegal under federal law 
(Thompson, 2015). Parents’ demands for alternate medications are forcing school 
districts and lawmakers across the United States to tackle the issue of administering 
medical marijuana during the school day (Jacobson, 2018).  
After years of attempting to keep marijuana out of schools, educators across the 
country now must address the issue of administering prescription medical marijuana to 
students (Terrell, 2016). When public school nurses administer medical marijuana to 
students, the schools are violating federal law—even though marijuana may be legal for 
medicinal purposes under state laws (DeNisco, 2016). Parents’ who choose to use 
medical marijuana are placed in the middle of the federal versus state (“tug of war.”) 
When states legalize medical marijuana, it puts schools in a position to have to choose 
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between following the federal law and the state law. Although medical marijuana is legal 
in 33 states and the District of Columbia, the federal government regulates drugs through 
the Controlled Substances Act (CSA), which does not recognize the difference between 
medical and recreational use of cannabis. Under federal law, cannabis is treated like 
every other controlled substance, such as cocaine and heroin. The federal government 
places every controlled substance in a schedule, in principle according to its relative 
potential for abuse and medicinal value. Under the CSA, cannabis is classified as a 
Schedule I drug, which means that the federal government views it as highly addictive 
with no medical value. Doctors may not "prescribe" cannabis for medical use under 
federal law, though they can "recommend" its use under the First Amendment (Gregorio, 
2014). 
  At least seven states have enacted laws or regulations that allow students to use 
medical marijuana on school grounds, knowing it could cause a potential showdown with 
the federal government and could risk their federal funding. So far, the federal 
government has not penalized any of the seven states. New Jersey, Maryland, Delaware, 
and Colorado permit parents to give their child non-smokable medicinal marijuana 
products at school. This summer, Colorado expanded its law to allow school staff to 
administer the medication. Washington and Florida allow school districts to decide for 
themselves whether to allow the drug on campuses. And Maine expanded state 
regulations to permit medical marijuana use at school, according to the Education 
Commission of the States (Railey, 2016). California’s legislation would let school boards 




 The disconnect between state and federal law poses inconsistent implementation 
policies and practices on the school level. The schools want to adhere to the Drug Free 
Schools Act (DFSA) a federal law which states drugs are not allowed on school grounds 
(Moore, 2018). This act puts school officials, and anyone who administers medical 
marijuana in jeopardy of losing their credentials if a medical marijuana policy is 
implemented. This act is a federal law and supersedes state law, however states have 
created laws for medical marijuana use. The parents and local officials who have 
successfully lobbied for laws that allow medical marijuana use in their states continue to 
face legal battles because of the DFSA. 
Nationwide, some families have been negatively affected by their schools’ refusal 
to allow staff to administer prescribed medical marijuana to students (Jacobson, 2018). 
As a result of this refusal, students are prohibited from receiving their prescribed 
medication while receiving a public education.  Schools have implemented policies that 
require students to go home in the middle of the school day to take their medication, 
meaning, these students often complete only a half day at school. When students are 
denied their prescribed medication, or they must leave in the middle of the school day to 
take their medication, their daily routine is disrupted, and their academics and social-
emotional development suffer (DeNisco, 2016). 
Medical marijuana policy is rapidly evolving in the United States and elsewhere. 
Marijuana sales are legalized and regulated in some jurisdictions, and the use of the drug 
for medicinal purposes is permitted in many others. Amidst this political change, patients 
and families are increasingly asking whether medical marijuana and its derivatives may 
have therapeutic use for several conditions, such as epilepsy and ADHD, including 
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developmental and behavioral disorders in children and adolescents (Hadland, Knight, & 
Harris, 2015).  
Marijuana is a plant that is also referred to as cannabis. It is composed of up to 80 
different chemical compounds. The two most researched compounds are 
tetrahydrocannabinol (THC) and cannabidiol (CBD). THC and CBD have an immediate 
effect on the brain. They connect with receptors of the brain and influence cognition, 
memory, motor movements, and pain perceptions (Richards, Smith, & Moulin, 2017). 
THC is the main psychoactive chemical in marijuana, and it continues to be classified as 
a drug. It affects the body in several ways. THC influences body temperature, pulse rate, 
anxiety, sedation, reduction of pain, and short-term memory (Greener, 2018). It is also 
the chemical that creates a euphoric high that is experienced by recreational users. CBD 
has physiologic effects that impact mood, memory, sleep, and appetite (Gonzalez & 
Swanson, 2012). Project CBD (2019) posits that “CBD is a naturally occurring 
compound found in the resinous flower of cannabis Project CBD 2019 (p. 1). “A safe, 
non-addictive substance, CBD is one of more than a hundred ‘Phyto cannabinoids,’ that 
are unique to cannabis and endow the plant with its robust therapeutic profile” (p. 1). 
Greener (2018) suggested that medical marijuana has been used since 1500 BC. He 
explained that ancient Egyptians used marijuana-like concoctions to treat numerous 
diseases and symptoms. Greener (2018) also documented that cannabinol was used as an 
enema and anti-inflammatory ointment and mixed with celery, as a topical treatment for 
eye disease. Healers across much of the ancient world have found medicinal value in 
marijuana (Greener, 2018). Persians caring for the sick over 2,700 years ago could 
choose from more than 10,000 medicinal plants to cure sickness (Gonzalez & Swanson, 
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2012). Research suggests marijuana has been healing illnesses for centuries. The benefits 
of the natural plant encouraged medical professionals to begin exploring its capabilities 
for treating and possibly healing conditions such as epilepsy, cancer, MS, and migraines 
(Greener, 2018). Many parents of children with epilepsy and attention deficit 
hyperactivity disorder have explored MM and CBD treatments. Children with Dravet 
syndrome (a rare form of epilepsy in children) have benefitted from use of marijuana 
(Wiederman, 2017). 
For purposes of this study, the term MM will refer to any part of the marijuana 
plant that is used to alleviate a health problem. It will also be used to refer to topical oils 
and products used as a treatment for illness. The literature refers to medical marijuana as 
a treatment that can be ingested and for topical use. Participants who were interviewed 
for the study shared during the interview process that medical cannabis is the term they 
prefer to use when referring to their child’s treatment. THC has been the plant’s most 
frequently researched chemical, and it is believed to affect the human body in several 
ways. It has been documented that THC assists with pain reduction, inflammation 
reduction, and improving problems in muscle control (Thompson, 2015). Additional 
research conducted by Gonzalez and Swanson (2012) stated that THC can increase pulse 
rates, perceptions of time, and body temperature.  
Medical marijuana can be ingested and used in a vapor form. It can be inhaled or 
smoked, which is reported to be the fastest route for immediate relief. It is also prescribed 
in the form of a cream or an oil for topical application. This method takes 2-3 hours to 
become absorbed by the bloodstream and have an effect (Richards et al., 2017). 
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Consumers use recreational marijuana, which is laden with CBD oil. The 
recreational users consume marijuana in the form of vapor, topical oil, and edibles such 
as brownies, gummy candy, cake, and hard candy. The allure of recreational marijuana 
and its consumption make it appealing to many youth (Richards et al., 2017). 
Recreational marijuana creates a barrier when trying to explain the benefits of medical 
marijuana, although both contain CDB oil, they have quite different uses and effects on 
brain function. Medical marijuana is currently used for pain reduction, Alzheimer’s 
disease, stroke, MS, and Parkinson’s disease (Bridgeman & Abazia, 2018). It is used for 
pain reduction in conditions related to rheumatoid arthritis and cancer. In addition to 
epilepsy and ADHD, it has been known to support anti-tumor effects, treatment for 
schizophrenia, stress disorders, and seizures (Gonzalez & Swanson, 2012). 
The legalization of MM has been at the forefront of health and policy discussions 
for several years in the United States (DeNisco, 2016). Morning news shows with 
political pundits, radio commentaries featuring medical experts, and newspaper articles 
with op-eds from esteemed health professionals, have each captured a different 
perspective on the issue (Gupta, 2014). Some proponents of medical marijuana suggest 
that the drug can assist those with chronic conditions (Gonzalez & Swanson, 2012). 
Naysayers argue that medical marijuana can have harmful social and medical effects 
(Gupta, 2013). 
Medical professionals have raised the possibility that students could benefit from 
the assistance of MM to stabilize chronic conditions and increase performance in school 
(Mouhamed et al., 2018). However, federal drug prohibition laws do not align with state 
MM laws governing administration in public schools. As of this writing, federal law bans 
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MM, while various states have passed legislation allowing the administration of MM in 
non-vapor form on school grounds.  Parameters for the use of MM in the sanctioned 
states varies greatly from school to school and district to district. Consequently, school 
district administrators are debating whether to risk violating federal law to allow state-
legalized marijuana on campuses to assist students (Terrell, 2016).   
Epilepsy is a common neurological disease that affects one in 26 people at any 
point in their lifetime. Today more than three million Americans, including almost 
400,000 children, live with epilepsy, with one-third living with treatment-
resistant seizures (Brooks-Kayal, 2021).  An estimate of 100,000 U.S. children have 
intractable epilepsy—a treatment-resistant category of the disease characterized by 
uncontrolled seizures—and for some of their parents, MM has gained a reputation as a 
wonder drug for treatment. Currently individuals who sell Charlotte’s Web, a strain of 
MM used for epilepsy treatment—say they have a waiting list of more than 12,000 
families, with many relocating to the state of Colorado to access the product (Pickert, 
2020). 
The Individuals with Disability Education Act (IDEA) (2004) mandates that all 
children with disabilities receive a free and appropriate public education in the least-
restrictive environment in American schools.  Districts are required to provide the 
accommodations needed for students to benefit from instruction. Thus, the IDEA appears 
to leave space for the administration of MM on school campuses to students who could 
benefit from the drug (Moore, 2018). However, the federal government also bans the 
possession or use of illegal drugs, including state-legalized MM, within 1,000 feet of any 
school. Any school district that chooses to allow MM treatment in school is violating this 
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law, which could potentially jeopardize federal funding and certification as a public 
school (Moore, 2018).   
Since 1999, 33 states and the District of Columbia, have legalized medical 
marijuana (ProCon.org, 2019). Maine became the first state to require all school districts 
to create a policy on the use of MM (Maine State Legislature, 2019). In 2016, Colorado, 
Maryland, and New Jersey passed laws permitting certain students to receive MM 
treatment in K-12 schools (DeNisco, 2016). Laws in the state of Washington do not 
require schools to permit on-site administration of MM but allow schools to choose 
(Railey, 2016). New York State has a proposal presented by Governor Andrew Cuomo’s 
administration, that would require the state health department to develop guidelines 
giving schools a way to possess, secure, and administer medical marijuana products 
under limited circumstances (New York State Department of Health [NYSDOH], 2019). 
These mixed responses demonstrate the disarray across the country regarding medical 
marijuana.   
Research and media reports have documented the positive effects of medical 
marijuana for various subsets of the population including those who suffer from post-
traumatic stress disorder (PTSD) and anxiety disorders (Mouhamed et al., 2018). 
Chemotherapy and war-related conditions can also be treated with MM (Tambaro & 
Bortolato, 2012). This study of parents’ perspectives will explore the implementation of 







Healthcare professionals sometimes prescribe MM to students who have 
neurological disabilities (Moore, 2018). Incongruous state and federal regulations have 
complicated, and at times, prevented the administration of medical marijuana to students 
in K-12 public school settings (Railey, 2016). This lack of access can potentially lead to 
difficult and nonproductive learning environments for students who are prescribed the 
medication (Terrasi & de Galarce, 2017).  
Parents who have selected MM as the treatment for their children diagnosed with 
epilepsy and/or ADHD, have faced barriers and challenges when the treatment must be 
administered during the school day. Children who have been diagnosed with these 
conditions have benefitted from the use of MM (Wiederman, 2017). This study explored 
the implementation of MM policies in New Jersey, Maryland, and Colorado school 
districts. It described the implementation of current medical marijuana policies in K-12 
schools and the impact on parents’ perspectives of their children’s ability to achieve their 
full academic and social/emotional potential. The experiences of parents are an important 
part of the conversation needed to create effective policy (Burke & Goldman, 2015). 
Policy makers are often concerned with the views and voices of parents (Burke & 
Goldman, 2015). Parent advocacy is also essential for the school/home partnership 
(Smith, 2014). Parents’ selection of alternative treatments for their children offers another 
avenue to foster the process of public school/home collaboration (Smith, 2014).  
Theoretical Rationale 
Implementation theory was used to guide this research. Implementation science 
examines theoretical approaches to provide better understanding and explanation of how 
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and why implementation succeeds or fails (Nilsen, 2015). Implementation science is 
defined as the scientific study of methods to promote the systematic uptake of research 
findings and other evidence-based practices into routine practice to improve the quality 
and effectiveness of health services and care (Nilsen, 2015). The terms knowledge 
translation, knowledge exchange, knowledge transfer, knowledge integration, and 
research utilization are used to describe the overlapping and interrelated research of 
putting various forms of knowledge, including research, to use with practice (Nilsen, 
2015).  
Implementation is part of a diffusion-dissemination-implementation continuum: 
diffusion is the passive, untargeted, and unplanned spread of new practices; 
“dissemination is the active spread of new practices to the target audience, using planned 
strategies; and implementation is the process of putting to use or integrating new 
practices within a setting” (Nilsen, 2015, p. 216). Theoretical approaches used in 
implementation science have three overarching aims: describing and/or guiding the 
process of translating research into practice (process models); understanding and/or 
explaining what influences implementation outcomes (determinant frameworks, classic 
theories, implementation theories); and evaluating implementation (evaluation 
frameworks) (Nilsen, 2015).   
Implementation science theory is implementation research that attempts to solve a 
wide range of implementation problems; it has its origins in several disciplines and 
research traditions (Nilsen, 2015). Implementation research can consider any aspect of 
implementation, including the factors affecting the implementation, the processes of the 
implementation, and the results of the implementation, which also can include how to 
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introduce potential solutions into a system or how to promote large-scale use and 
sustainability (Nilsen, 2015). The intent for using implementation theory was to 
understand what, why, and how the MM policies in K-12 public schools were successful 
and how they could be improved. 
Statement of Purpose 
The purpose of this narrative study is to examine parents’ experiences with the 
implementation of MM policies in K-12 public schools in New Jersey, Maryland, and 
Colorado. It is important to give a voice to parents who choose this method of treatment. 
The parents’ perspectives and experiences may provide a blueprint for school districts 
when developing a policy to allow MM administration on school grounds. This study 
focused on the ways schools have supported the parents’ decision to treat their children 
with MM, the parents’ understanding of the impact of the policy on their children’s 
academic and social progress, and how the health of these children has been affected by 
the schools’ implementation policies. The information gained from this study can be used 
to inform policy development and school programs.   
Burke and Goldman (2015) suggested the role many parents have assumed 
includes being an advocate, cheerleader, and champion for their children’s academic and 
social success.  Parents seeking a policy for a MM treatment plan in K-12 schools is an 
example of advocacy. Potentially it could lead to students having better school 
performance and lead healthier lives. (Moore, 2018). However, these students may not be 
afforded such opportunities due to state and federal law discrepancies regarding the use 




The research questions to be answered by this study are:   
1. Given current medical marijuana policies, how do parents describe their 
experiences implementing their children’s treatment plans? 
2. How does medical marijuana policy impact parents’ perceptions of their 
child’s performance in school?  
3. How do parents describe the implementation of existing medical marijuana 
policy on their children’s social and emotional development? 
Significance of the Study 
 The significance of this study is the data it provides to inform MM policy 
decisions both at the state and local school board level. The partnership between home 
and school is crucial to student success (DeNisco, 2016). The descriptive experiences of 
parents provide information to school districts nationwide.  This research also provides 
insight into how parents and schools may help students who are treated with MM to 
maximize their academic, social, and emotional outcomes in school.   
This research increases information and knowledge by including the perspective 
of parents whose children are identified as students with disabilities and use a treatment 
plan that includes MM. School districts across the country may finally have a template to 
use that may enable students to have greater access to K-12 instruction and school 
sponsored recreational activities by developing policies that facilitate implementation of 





Definitions of Terms 
The following terms are defined that will be used in this study: 
Attention Deficit Hyperactivity Disorder – Five or more symptoms of inattention 
and symptoms of hyperactivity/ impulsivity must have persisted for 6 months to a degree 
that is inconsistent with the developmental level and negatively impacts social and 
academic/ occupational activities (CDC.org, 2018)     
Cannabis – a plant that is also referred to as marijuana (CDC.org, 2018). 
Cannabidiol (CBD) – a compound found in marijuana/cannabis (CDC.org, 2018). 
Evidence-Based Practices – an interdisciplinary approach to clinical practice that 
has been gaining ground following its formal introduction in 1992. It started in the 
medicine field and spread to the allied health professions, educational fields, and other 
fields (Nilsen, 2017). 
Marijuana – a plant that is also referred to as cannabis (CDC.org, 2018).  
Medical Marijuana (MM) – cannabis that is used for medicinal purposes, 
comprising up to 80 chemical compounds. The two most researched compounds are THC 
and CBD (CDC.org, 2018).  
Medical Marijuana Laws – legislation involving medical marijuana/cannabis for 
research studies (Newman, 2018). 
Primary Care Physician (PCP) - a person who provides first contact for a person 
with an undiagnosed health concerns and provides continuing care of varied medical 
conditions (Hopfer, 2014). 






The potential positive outcomes achieved by medical marijuana treatment have 
encouraged parents to choose MM as the treatment plan for children diagnosed with 
epilepsy and attention deficit hyperactivity disorder. These treatment plans for students in 
K-12 schools require midday administration and have caused debate in the educational 
systems in New Jersey (Railey, 2016). The use of MM has been introduced into 
legislation and policy in 33 states and the District of Columbia (DeNisco, 2016). Parents 
of students have begun to administer MM to their children as an alternative to traditional 
medicine (Moore, 2018).  However, students in K-12 schools have faced barriers 
regarding the administration of MM on school grounds (Railey, 2016). This study will 
use a qualitative narrative study approach to conduct interviews with parents of children 
who are treated with MM.  It strives to describe their experiences with the administration 
of MM in K-12 schools in New Jersey, Maryland, and Colorado. The study will inform 
K-12 schools about best practices for the development and implementation of MM 
policies. The hope is that these policies will create an academic environment where all 
students can aspire to reach their maximum learning potential and feel included in their 
school communities. 
Chapter 2 reviews the literature on MM including research into medical 
marijuana’s positive and negative effects, implications of medical marijuana use in 
adolescents, and the barriers to the use of MM in schools. Chapter 3 describes the 
research methodology for this study. Chapter 4 provides the findings of the study and 
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Chapter 5 discusses implications of the findings along with recommendations for the 
future.   
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Chapter 2: Review of the Literature 
Introduction and Purpose 
Thompson (2015) opined that the use of MM benefits the lives of many people 
who suffer from life challenging illnesses and conditions such as MS, epilepsy, autism, 
and glaucoma. Parents are choosing treatment plans that include the administration of 
medical marijuana to their children in a non-vapor form (Thompson, 2015). Parents are 
requesting that school districts support their decisions by developing implementation 
policies that permit the administration of MM in K-12 schools (Railey, 2016). Many 
school districts grapple with the idea of administering MM because it is classified as a 
Type 1 drug on the federal level, and therefore cannot be administered within schools. 
School districts risk sanctions including the loss of federal funding if they do not adhere 
to federal laws (DeNisco, 2016). As states continue to pass legislation to legalize MM, 
parents are trapped in a political tug of war between federal and state laws (DeNisco, 
2016). In this study, the parent participants shared their experiences with the 
implementation of MM policies in the schools attended by their children. The literature in 
this section illustrates the perspectives and the pros and cons of the use of MM. 
The use of medical marijuana as part of the treatment plan for students who attend 
public schools has created difficulties for state and federal lawmakers, students, school 
districts, and parents/guardians (DeNisco, 2016). Greener (2018) posited that some 
parents’ choice to select MM as a treatment plan for their children may benefit the lives 
of students who suffer from life changing illnesses and conditions such as MS, epilepsy, 
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autism, and glaucoma. In most cases, medical marijuana is used in the form of an oil 
(cannabis oil), which can be ingested either through food or drink. While medical 
marijuana has been legal in some states for almost two decades, it is still illegal under 
federal law. Parents’ demands for alternate medications are forcing school districts and 
lawmakers across the United States to tackle the issues regarding the administration of 
medical marijuana (Jacobson, 2018). After years of attempting to keep marijuana out of 
schools, educators across the country now must address the problem of administering 
medical marijuana to students. When public school nurses administer medical marijuana 
to students, the schools are violating federal law—even though marijuana use may be 
legal for medicinal purposes under state law (Hakalovic, 2016). Each state has outlined 
guidelines for use of medical marijuana.  Currently although it is prescribed by a doctor, 
the dosage is only a recommendation. This recommended dosage presents a problem for 
school nurses. In some states, nurses can only administer medicines with prescribed 
dosage (Jacobson, 2018). 
Nationwide, families have been negatively affected by some schools’ refusal to 
allow their staff to administer marijuana to students (DeNisco, 2016). As a result, 
students may be prohibited from receiving their medication while attending public 
schools (Moore, 2018). Some districts have implemented policies that require students to 
go home in the middle of the day to take their medication.  These students often complete 
only a half day at school (Hakalovic, 2016). When students are denied their medication or 
they must leave in the middle of the school day to take their medication, their daily 





Review of Literature 
The reality of using medical marijuana as an effective treatment is supported by 
research. This literature review begins by examining the illnesses that benefit from 
medical marijuana use. Next, the literature review illustrates the use of medical marijuana 
as a treatment for children with epilepsy and attention deficit hyperactivity disorder. It 
also highlights medical professionals’ experiences with medical marijuana. It concludes 
with the positive effects and the challenges associated with medical marijuana use for 
children.  
Benefits of Medical Marijuana  
Parents seeking alternative methods for the treatment of their children’s chronic 
conditions may choose medical marijuana for its documented benefits (Grinspoon, 2018). 
Parents are looking to medical marijuana as a treatment (Jacobson, 2018). According to 
Grinspoon (2018), “medical marijuana is proven to ease the pain of MS and nerve pain in 
general, which is quite effective for chronic pain that plagues many Americans, 
especially at an early age” (p. 2). Grinspoon (2018) stated medical marijuana is safer than 
opiates and patients claim that marijuana allows them to resume their previous activities 
without feeling completely out of it and disengaged. The components of medical 
marijuana are said to work as a muscle relaxant with some proponents of the drug 
believing it can lessen tremors in Parkinson’s disease (Thompson, 2015). The use of 
medical marijuana has been explored in treatment of veterans who are returning from 
combat zones (Mammoser, 2017). Many veterans and their therapists reported drastic 
improvement (Mammoser, 2017). Grinspoon (2018) reported the use of medical 
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marijuana to help patients suffering from pain and wasting syndrome associated with 
HIV, as well as it being effective for irritable bowel syndrome and Crohn’s disease. The 
Epilepsy Foundation states MM could help control seizures due to epilepsy disorders 
(Nielsen, 2017).  
 Parents with children who have seizures and various forms of epilepsy are 
exploring medical marijuana as a cure. In a study conducted by Devinsky et al. (2016) 
368 patients with Lennox-Gastaut syndrome (LGS), a severe condition characterized by 
seizures (epilepsy), participated in one of two randomized controlled trials that evaluated 
the long-term efficacy of MM. Patients were given a pharmaceutical formulation of MM 
in an oral solution form over a 38-week period. The results indicated patients experienced 
diarrhea at moderate to severe levels at 23% to 43%.  The patients also experienced a 
reduction in seizure frequency from 60% to 48% monthly. The findings reported a 
decrease in seizure frequency; however, they also reported an increase in diarrhea. The 
study suggested additional trials to expand research.  
The benefits of the drug are also being explored to treat chronic pain and mood 
disorders.  Habib and Artul (2018) conducted a study that identified participants with 
fibromyalgia (a chronic pain syndrome, characterized by chronic musculoskeletal pain, 
fatigue, and mood disturbances). This open study included 26 patients who were given a 
pre- and post-impact questionnaire regarding the MM treatment.  All patients reported a 
significant improvement in every parameter on the questionnaire. Fifty percent of patients 
stopped taking any other medications for fibromyalgia. Thirty percent of patients 




The studies conducted by Devinsky et al. (2016) and Habib and Artul (2018) 
illustrated the benefits of MM use. They also indicated the need for additional testing and 
increased sample size. The federal classification of marijuana as a type 1 drug presents 
challenges for research funding (Grinspoon, 2018). The benefits of using MM is 
documented, however some studies illustrate cognitive deficits in MM users, primarily in 
the areas of memory and learning. Bostwick’s (2018) studies found no significant effects 
connected to memory loss. A review of MM studies conducted by Hirst, Watson, Rosen, 
and Quittner (2018) revealed mixed findings regarding the neuropsychological effects of 
MM. Eight vignettes, each showing marijuana users varying in age, gender, and history 
of marijuana use, showed broad but mild cognitive deficits and memory loss (Hirst et al., 
2018). 
Cancer patients who have used MM as a treatment plan experienced mixed 
reactions to MM use. Saadeh and Rustem (2018) conducted a study to compare the 
incidence of marijuana use by patients with early versus advanced-stage cancers. Using a 
self-reported questionnaire, adult patients who received chemotherapy were asked to 
report their use of marijuana. Of the 175 patients, 32 (18.8%) reported use of marijuana. 
Early-stage patients, 19.6% (11 out of 56 patients), versus late-stage cancer patients, 
17.6% (21 out of 119 patients), reported more pain and nausea associated when using 
marijuana; this caused patients to stop using MM as a treatment. The studies revealed 
mixed results indicate MM use is not a cure for all. The results are also inconclusive 
regarding the dependency of MM and its benefits. The findings indicated MM has many 
positive benefits; however additional studies are needed. The benefits of MM were 
highlighted in studies conducted by Devinsky et al. (2016) and Habib and Artul (2018). 
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Researchers, however, continue to yield mixed results of the long-term benefits of 
marijuana (Hirst et al., 2018). Medical uses for marijuana will benefit from more research 
and studies into its efficacy.  
Medical Marijuana Treatment for Epilepsy and ADHD 
Doctors who treat children with epilepsy and attention deficit hyperactivity 
disorder have suggested MM as a treatment for children who are diagnosed with those 
conditions.  Narratives reporting the ability of MM to alleviate seizures have been 
discussed for over a century (Grinspoon, 2018). Now that MM is becoming a topic of 
interest and is legal in over 30 states, trials are being conducted to determine the potential 
benefits of medical marijuana for seizures (Privratsky, 2018).  
Orrin Devinsky, a neurologist at New York University Langone Medical Center, 
and his colleagues across multiple research centers, published the results from the largest 
study to date of a cannabis-based drug for treatment-resistant epilepsy. The researchers 
treated 225 patients ages 2 to 55 in a randomized control trial. The trail was to assess the 
efficacy and safety of doses of MM. Seizure activity was monitored for a 4-week period 
prior to the start of the study. The trial tracked seizures throughout a 14-week study 
period. The researchers reported side effects were mild and included sleepiness and 
diarrhea. The results showed a 39% drop in seizure frequency. The study provided 
promising results for epilepsy. Devinsky (2016) stated “this an extraordinary time for 
epilepsy and MM is one of the most prominent and exciting treatments coming out, 
however we lack data for some epilepsy syndromes” (p. 1).  Kevin Chapman, a 
neurology, and pediatric professor at the University of Colorado School of Medicine, 
who was not involved in the Devinsky study said, “I think this study provides some good 
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data to show that it's relatively safe to use MM and it can reduce seizure and increase 
quality of life—the adverse effects were mostly mild” (Groce, 2018, p.17). 
The medical community is beginning to suggest MM as an option to treat 
seizures. An open study conducted by Hausman-Kedem, Menascu, and Kramer (2018) 
targeted 57 patients ages 1-20 with epilepsy using oral administration of MM. The focus 
of the operational longitudinal study was to evaluate the efficacy of MM for the treatment 
of epilepsy. The study was conducted over 3 months and 46 patients participated. The 
results indicated a significant reduction in seizure frequency according to parental 
reports.  It was noted that randomized controlled trials are necessary to assess its true 
efficacy.  
Parents seeking alternative treatments for their children with seizures are choosing 
MM. The parent of a MM user stated that children with hard-to-treat epilepsy may find 
using a strain of MM called Charlotte’s Web beneficial.  This strain might make 
treatment for children easier to manage because it does not produce the feeling of being 
intoxicated or high (Brown, 2018). The THC levels in the Charlotte’s Web strain are very 
low: the CBD amounts are high (Rosado, 2018). Prescribing MM to children is a recent 
pathway of treatment.  Due to the Food and Drug Administration (FDA) identification of 
MM as a drug, studies are limited, and more are needed to provide conclusive data 
(Rosado, 2018).  The studies conducted by Devinsky et al. (2016) and Hausman-Kedem 
et al. (2018) identified MM as an effective treatment to explore for children with 
epilepsy. The studies highlighted the need for more testing and trials to determine proper 
dosage for children.  
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Medical marijuana has been explored as a treatment for attention deficit 
hyperactivity disorder.  A 15-year-old boy diagnosed with ADHD was the subject of an 
uncontrolled case report. This report was written by Richards et al. (2017) Its purpose 
was to provide information on how to improve tics and reduce the number of stimulants 
associated with ADHD. The results indicated that the tics were considerably improved 
without adverse effects. The number of stimulants associated with ADHD were reduced. 
The report indicated further studies were needed to substantiate findings. The report’s 
case studies illustrated the benefits of using MM as a treatment plan for epilepsy and 
ADHD. It also indicated the need for additional research and randomized testing using 
MM for epilepsy and ADHD. 
Blurred Lines - Medical Marijuana versus. Recreational Marijuana 
Medical marijuana is often confused with recreational marijuana. The blurred 
lines occur when addressing the benefits of MM. Some users of recreational marijuana 
state it reduces pain. Statements from recreational marijuana users make it difficult for 
naysayers of MM to separate the two drugs. The oppositional literature surrounding 
medical marijuana is associated with the blurred lines that confuse recreational marijuana 
and medical marijuana use.  Some studies have highlighted the overlapping confusion of 
medical marijuana and recreational marijuana. Other opposition literature states MM has 
had no or minimal positive effect. In some instances, MM treatment has been associated 
with a worsening of seizures or other serious side effects leading children to be 
hospitalized (Brooks-Kayal, 2021).  The limited studies surrounding MM has made it 
difficult to produce concrete results (Grinspoon, 2018). In a Canadian study of 104 
human immunodeficiency, virus-positive adults, 43% reported botanical cannabis use in 
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the previous year. Two-thirds of the patients experienced symptoms ranging from 
appetite stimulation and sleep induction to antiemesis and anxiolysis; 80% of this group 
also used the botanical cannabis recreationally (Bostwick, 2012). Bostwick’s (2012) 
comprehensive research work included a comprehensive literature review. The literature 
review indicated MM and recreational marijuana are sometimes both consumed by 
patients. The consumption of both makes it difficult to discern the effectiveness of 
medical marijuana.  
According to Bostwick (2012), a team of Canadian investigators interviewed 50 
self-identified medical cannabis users, finding that “typically MM use was followed by 
recreational use and the majority of those interviewed were long-term and sometimes 
heavy recreational users” (p. 174). Blurring the boundary between medical and 
recreational use still further, Bostwick (2012) included in his literature review interviews 
with more than 4,100 Californians who were deemed medically ill. The information 
revealed that the medically ill patients preferred inhaling their medication and vapor 
inhaled consumption is often the preferred method to consume recreational marijuana 
(Bostwick, 2012).  
According to Bostwick (2012), MM is easier to control by users when they 
consume it in a vapor form. The other methods of consumption are less favorable to use 
with adult patients. The literature review noted that medical marijuana users may 
consume less than recreational users. Users of MM inhale only enough to produce the 
desired clinical effects. When MM is ingested in vapor form it is often associated with 
the previous illegal use of the drug. However, when consumed in the form of vapor it also 
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has the potential to reduce respiratory symptoms and decrease negative effects on 
pulmonary function (Mammoser, 2017).   
 Saddeh and Rustem (2018) conducted a study which incorporated 400 different 
chemicals from 18 different chemical families, with MM containing more than 2,000 
chemical compounds. The purpose of the study was to compare the incidence of medical 
marijuana use by people who are diagnosed with early-onset seizure and prolonged 
seizures. The results showed that short-term cannabis use can cause decreased heart rate 
and blood pressure. However, when ingested in a vapor form over a 5 year period, 
cannabis can increase the toxins in the body. The findings revealed that cannabis smoke 
contains many of the same toxins found in tobacco smoke. Although MM toxins were 
found in the participants of the study, these toxins are less harmful than many toxins in 
prescribed medicine for seizure disorders (Saadeh & Rustem, 2018). 
Bostwick’s (2012) literature review and studies conducted by Saadeh and Rustem 
(2018), indicated the preferred method for consumption of medical or recreational 
marijuana is inhalation. This method has been proven to be effective (Saadeh & Rustem, 
2018). However, the method delivery (i.e, inhaling) is stigmatized and reduces the 
argument in support of the need for medical marijuana (Jacobson, 2018).  
Testing to identify the benefits of MM continues to show some areas of definite 
benefits. Parent and anecdotal data indicated reduced seizures and improved health for 
children. It also recommends the need for additional resources to produce substantive 
findings (Brown, 2018). The findings are based mainly on trials and parent and doctor 
anecdotal findings, which are inconclusive and result in inconsistent results (Grinspoon, 
2018). The federal and state laws are incongruent regarding marijuana use. Bostwick 
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(2012) indicated in his literature review the blurred lines regarding medical and 
recreational marijuana. These blurred lines make it more difficult to convince naysayers 
of the benefits of MM. There is research that supports the growing benefits of MM use 
and the increasing need for additional research.  
Medical Professionals and Medical Marijuana 
Medical opinion varies regarding the benefits of MM. There are different stages 
of acceptability based upon the physician’s exposure and training. Medical marijuana has 
been glorified, demonized, and now increasingly used as a medical treatment plan 
(Kleber & Dupont, 2012). Although there is a vast amount of money directed towards 
political campaigns to legalize MM in states, similar effort has yet to materialize in the 
medical community for MM research (Kleber & Dupont, 2012). The (FDA) has not yet 
determined the potency, purity, and composition of safe medical marijuana (Orberg, 
2017). This affects how it will be controlled. Many concerns are being raised about 
medical marijuana’s side effects, and long-term effects, especially in adolescents and 
young adults (Kleber & DuPont, 2012). 
Medical professionals have concerns about prescribing the correct dosage and are 
not quite sure if an exact dose exists (Bostwick, 2012). Currently, there is not one FDA-
approved medication that is available for smoking. Over the past 70 years, the average 
potency of THC has increased by 90% (Pettinato, 2017). The consumer has no way of 
knowing the accuracy or the purity of the product. A major concern of medical 
professionals is the potential risk to patients. Thompson (2015) suggested that marijuana, 
like all legal drugs, has possible risks. It can cause increased heart rate, which can 
increase chances for heart attack in people who are already at risk. It can be addicting and 
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can interfere with work, school, and relationships (Thompson, 2015). As medical 
professionals continue to assess the effectiveness of medical marijuana, studies suggest it 
can be an effective treatment for chronic pain, nerve pain, muscle spasms, glaucoma, and 
seizures (Boehnke, Gangopadhyay, Clauw, & Haffajee, 2019). Research has shown 
evidence of MM treatment efficacy across different conditions is not conclusive 
(Boehnke et al., 2019).  
Medical professionals are suggesting the creation of a nationwide patient registry 
that would unify medical marijuana’s usage and provide a better understanding. Currently 
a registry does not exist. As the legalization of MM in various states occurs, individual 
states create their own conditions and guidelines for use. Some states are requiring 
patients with prescriptions to register with the state. This tracking system should begin to 
help medical professionals (Kondrad & Reid, 2013). More studies on the use and effects 
are needed to help doctors unify and become confident in providing prescriptions 
(Pettinato, 2017). 
The relationship between primary care professionals (PCP) and patients is 
significant in the conversation around MM (Bostwick, 2012). Kondrad and Reid (2013) 
conducted a study with 17 patients; 11 stated they were prescribed MM from a doctor 
other than their primary care physician, and six patients said a doctor at a dispensary 
recommended MM. One of the 17 patients indicated his primary care physician 
recommended MM for his chronic pain management. The most common reason for the 
prescription was cited as severe pain (Kondrad & Reid, 2013). Patients did not feel 
comfortable consulting with their PCPs regarding the use of MM as a treatment plan.  
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Medical marijuana is increasingly becoming a requested treatment plan for 
individuals (Pickert, 2021). Boehnke et al. (2019) noted that currently there is no 
agreement in the medical community about the use of prescription MM. The research 
conducted by Kondrad and Reid (2013) has shown that there is also an issue with patient-
doctor communication regarding the patient’s true use of marijuana.  
In another study conducted by Kondrad and Reid (2013), paired surveys were 
distributed to primary care physicians and their patients to identify frequency of patient 
marijuana use and communication with the PCPs regarding that use. The results showed 
poor communication between the patients and the PCPs. Of the 242 patients who 
participated in the survey, 22% reported marijuana use in a half-year time frame. Those 
who identified as MM users were 61% of the respondents. The PCPs were aware of 53% 
of their patient’s usage (Kondrad & Reid, 2013). The studies conducted by Kondrad and 
Reid illustrate the need for trust between doctors and patients. Patients are reluctant to 
share their choice of MM treatment with PCPs. The lack of knowledge and research 
regarding medical marijuana in the medical community poses a barrier for medical 
professionals to discuss with patients. 
Medical professionals are seeking additional training about MM treatment plans. 
Grinspoon (2018) conducted surveys on medical students, those findings revealed that 
almost 90% of physicians in the final stages of their training—residents and fellows—felt 
they were not at all prepared to prescribe MM, and more than one-third of the participants 
felt they were not able to accurately answer questions about MM. Almost 85% of the 
participants reported receiving no education about MM during medical school or 
residency. The study identified that one in 10 medical schools include teachings or 
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curriculum regarding MM (Grinspoon, 2018). This lack of education limits the 
conversation and information that primary care providers can share with their patients 
(Grinspoon, 2018). 
The findings from Grinspoon (2018) suggested that PCPs are probably aware of 
their patients’ use of traditional medications, but they are not likely to know about their 
patients’ marijuana use. As a result of mixed perceptions regarding the topic, many 
patients might feel they would be judged negatively if they inquired about the benefits of 
MM with their PCPs (Grinspoon, 2018). The lack of knowledge that PCPs have 
regarding MM becomes a challenge for them to initiate and/or discuss a treatment plan as 
an option for their patients (Kondrad & Reid, 2013).  
Beliefs, stigmas, and lack of research continue to raise questions regarding the 
benefits of MM (Grinspoon, 2018). Medical professionals are seeking training to answer 
patients’ questions regarding MM. Lack of information and training make medical 
professionals feel unqualified to prescribe MM. Many of the questions posed by medical 
professionals also remain key considerations in policy makers’ inability to come to a 
consensus regarding medical marijuana (Grinspoon, 2018). 
Medical Marijuana Uses for Children 
Medical marijuana is becoming more popular as a chosen treatment plan for 
children. A growing number of parents across the country are turning to medical 
marijuana to treat their children—often after pharmaceutical methods have been 
unsuccessful (Carbone, 2018). Parents reported improved quality of life and a sense of 
normalcy with MM use (Klumpers et al., 2012).  
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Bellano (2015) reported that the mother of a 5-year-old California girl who could 
bring MM to school, said “I was so overwhelmed with joy that we don’t have to keep 
pushing to get what she needs, she can just go to school like any other child” (p. 2). Like 
the child in California, the number of children in Delaware receiving MM is rapidly 
climbing (Newman, 2018). For a child in Delaware to receive MM, both parents and a 
licensed physician need to provide consent (Newman, 2018). Another positive factor for 
children is that long-term use of MM can be effective in treating seizures and 
chemotherapy-induced nausea in young patients. Mammoser (2017) conducted a meta-
analysis that looked at 22 relevant studies on the use of MM with adolescents and 
children. Mammoser (2017) supported MM use for children but cautioned against the 
psychoactive effects like memory loss and difficulties with concentration.   
Parents relate the success their children are experiencing while using MM as a 
treatment plan (Ryan et al., 2020). However, some researchers have conducted studies 
that demonstrated negative results. Studies have indicated that some side effects of MM 
could include short-term memory loss, higher psychosis rates, and decreased 
concentration in children (Ammerman, Ryan, & Adelman, 2015). Researchers have 
found there can also be harmful effects associated with MM use. Hopfer (2014) reported 
that one potential side effects of MM use, is the challenge it presents for adolescent drug 
prevention efforts.  The sanctioned use contrasts with messages of marijuana’s 
harmfulness. Hopfer (2014) researched Colorado medical marijuana usage and revealed 
that within 2 years, beginning in 2012, the use of MM increased from 2,000 patients to an 
estimated 150,000 patients. The report details that this increase in usage may have a 
connection to an increased high school dropout rate. It may also create marijuana 
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dependence for adolescents who used MM and were under 18 years of age (Hopfer, 
2014).  
Hadland et al. (2015) conducted a study to take a deeper look into the perceived 
riskiness of marijuana usage among different subgroups of high school seniors. Their 
findings indicated that between 2010 and 2016, youth who identified as MM users 
increased significantly, while the group that identified as recreational MM users 
decreased (Hadland et al., 2015).  
Other studies illustrate medical marijuana’s positive effects when used to treat 
children (Mammoser, 2017). The studies conducted by Mammoser (2017) report the 
medical benefits and need for additional research. The findings of Ammerman et al. 
(2015) were inconclusive regarding the impact of MM on a child’s development over an 
extended amount of time. In comparison to the parent data of Smith (2019) which 
reflected immediate positive changes and quality of life. Longitudinal research is needed 
to produce concrete data that can lead to conclusive decision making (Mammoser, 2017). 
Chapter Summary 
Some of the literature supports the decision of parents to choose a MM treatment 
plan (Mammoser, 2017). The research identified reasons for supporters and skeptics to 
have equal concerns (Smith, 2014). The literature agrees that MM may be a viable 
treatment plan (Thompson, 2015). The literature indicates MM is used for pain 
management and reduction of seizures. However, the literature also identified the 
overwhelming need for more research, longer testing trials, and larger sample size testing 
to gather consistent and concrete evidence regarding medical marijuana (Hadland et al., 
2015). The research described the positive effects of MM and the challenges presented by 
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the laws regarding its usage (Grinspoon, 2018).  Parents of students seeking alternatives 
to traditional medication will continue to be on the frontlines advocating for the 
implementation of policies in K-12 public schools. Those parents who choose a MM 
treatment plan will continue to be advocates for their children as they foster partnerships 
with schools regarding policies for homework, class and course offerings, and medical 
needs (Terrell, 2016). Chapter 3 describes the methodology that was used for this study, 
including the research context and design, the research participants, and the instruments 
and procedures that were used for the data collection and analysis. 
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Chapter 3: Research Design Methodology 
Parental decisions to choose MM treatment plans for their children who attend 
public schools have created uncertainty for state and federal lawmakers, students, school 
districts, and parents/guardians (Terrell, 2016). The use of medical marijuana benefits the 
lives of many people who suffer from life changing illnesses such as MS, epilepsy, 
autism, and more attention deficit hyperactivity disorder (Thompson, 2015). In most 
cases, MM is derived from a plant and is prescribed and used in the form of an oil 
(cannabis oil), which the patient can ingest either through food or drink. While MM has 
been legal in some states for almost two decades, it is still illegal under federal law 
(Thompson, 2015). Parents’ demands for alternate medications as treatment plans are 
forcing school districts and lawmakers across the United States to tackle the issues 
regarding students’ use of MM (Jacobson, 2018).  
The issue arises when students are prescribed MM treatment plans and cannot have 
it administered in school. Schools must comply with federal and state laws to qualify for 
state and federal funding. The funding issues become complicated when the federal and 
state laws conflict. Public schools must make a choice in some cases: Do we support our 
students’ parents and provide the treatment plan of choice, or do we comply with federal 
funding regulations and limit the use of medical marijuana in our schools (Terrell, 2016)? 
The MM policies are evolving in the United States, with marijuana sales fully 
legalized and regulated in some jurisdictions, and the use of marijuana for medicinal 
purposes permitted in many others (Terrell, 2016). Amidst this political change, patients 
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and families are asking whether MM and its derivatives may have therapeutic use for 
several conditions, including epilepsy and attention deficit disorder in children and 
adolescents (Hadland et al., 2015). New Jersey, Maryland, and Colorado are states that 
have permitted MM administration in public schools. Governor Chris Christie’s bill 
A4587 was inspired by a parent from Maple Shade, New Jersey. This parent sought legal 
recourse to administer MM treatment on school grounds after her request was denied by 
the school district (Livio, 2019). The bill was adopted in November 2015 making New 
Jersey one of the pioneer states permitting MM administration on school grounds. The 
purpose of this study was to develop an in-depth understanding of the experiences of 
parents like the one who inspired this legislation.  
Qualitative methodologies use focus groups or interviews as instruments for data 
collection. An in-depth interview was used for this narrative study. A three-dimensional 
space approach by Clandinin (2007) involving analyzing data for three elements: 
situation (physical places) interaction (personal and social), and continuity (past, present, 
and future).  Narrative researchers situate individual stories within participants’ personal 
experiences (their homes, their families) (Creswell, 2014). Five qualified candidates were 
chosen for interviews. The interviews were conducted via video conferencing, recorded, 
and notes were taken. The study captured notes in two parts: reflective in which the 
observer used video conferencing to record thoughts and ideas; descriptive in which the 







The research was conducted via Zoom with parents from New Jersey, Maryland, 
and Colorado schools; the selected participants had children in schools that had adopted 
legislation like New Jersey’s Bill 4587.  Adopted in November 2015, this legislation 
permits children who are prescribed MM to receive the treatment on school grounds.  
The researcher selected participants from on-line parent groups who consist of 
parents who have children with disabilities. The researcher selected parents who children 
are diagnosed with epilepsy and ADHD. 
Research Participants 
The population for this study consisted of the parents of five children who attend 
New Jersey, Maryland, and Colorado schools and have chosen MM treatment plans for 
their children. New Jersey, Maryland, and Colorado were the chosen locations because 
they have legalized the use of MM. These states also specifically permitted the 
administration of MM in K-12 public schools. Creswell and Creswell (2018) identified 
narrative sampling size guidelines for a narrative study as one to two cases. This study 
targeted five participants for the purposes of getting common themes of experiences and 
to obtain saturation.  The participants are parents of children who have been identified by 
their school districts as children with educational disabilities. Each participant 
collaborated with their school district to implement a MM policy. The following 
questions were qualifiers for participation in the study: 
1.Do you have a child or children of K-12 school age?  
2.How does medical marijuana policy impact parent’s perceptions of their child’s 
performance in school?? 
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3.Do you have children who attend school in New Jersey, Maryland, or Colorado? 
Research Design 
The purpose of this study was to highlight personal experiences that included 
successes and challenges implementing medical marijuana school policies.  This 
narrative study used a three-dimensional approach by Clandinin (2007) involving three 
elements: continuity (past. present, and future), situation (physical places) and interaction 
(personal and social). Huck (2016) identifies the narrative design approach as an 
approach that follows a chronology of events and situations. It is descriptive in sharing 
information (Huck, 2016).  The narrative, three-dimensional research design was chosen 
to capture the experiences of parents before medical marijuana implementation, during 
medical marijuana implementation and after medical marijuana implementation. This 
design will provide the framework for data collection throughout the entire 
implementation process. The three-dimensional approach aligned with the research 
questions and addressed the students’ experiences. The students’ academic performance 
after MM plan was implemented, addressed the present as indicated in the three-
dimensional approach. The student’s continuous social and emotional needs after the MM 
plan was implemented, addressed the future as indicated in the three- dimensional plan. 
There are not any prior studies pertaining to parents’ experiences with MM 
implementation in public schools. This study addressed the following research questions:  
1. Given current medical marijuana policies, how do parents describe their 
experiences implementing their children’s treatment plan? 
2. How does MM policy impact the parent’s perception of their child’s 
performance in school?  
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3. How do parents describe the implementation of existing medical marijuana 
policy on their child’s social and emotional development? 
Clandinin (2007) suggests narrative can be either a phenomenon of study or a 
method of study. It is best for capturing the detailed stories of a small number of 
individuals’ life experiences. The participants in this study were known to the researcher 
through membership in the Parents of Epilepsy group. It is a parent group with 
participants who were easily accessed by the researcher.  The names were taken from 
online group chats in the Parents of Epilepsy group. Then, the parents were contacted via 
e-mail. The initial e-mail was a letter of introduction. The e-mail letter of introduction 
introduced the study to the prospective participants, summarized the purpose of study, 
outlined the criteria for participation, and encouraged voluntary participation. After the 
notice of participation was received by the researcher, follow-up correspondence via e-
mail was sent, which included informed consent. Following the completion and return of 
the informed consent, interviews were scheduled. The researcher used the assigned St. 
John Fisher e-mail address or text, to communicate with participants concerning the 
interviews. The researcher arranged one interview for approximately 90 minutes either 
using face-to- face or telephone interviews. Using a variety of platforms audio/visual 
meetings, for example Zoom or Google Meets, the interviews were digitally, and audio 
recorded and transcribed by Rev.com. 
The letter of introduction was used to obtain information regarding the child, use 
of treatment plan, and school data (Appendix A).  The informed consent form provided 
the participants with information regarding the purpose of study, participation 
requirements of the study, and outlined the anticipated benefits and risks of participation 
 
38 
in the study, assured confidentiality, and addressed compensation issues. The form 
emphasized that participation in the study was voluntary. See Appendix B. 
Instruments Used in Data Collection 
The instruments used in data collection were chosen to ensure safety during the 
COVID- 19 pandemic, the researcher used only face-to-face digital interviews or audio 
interviews. The researcher used an electronic recording device and a note pad for notes. 
The researcher used semi-structured interviews for this narrative study. The interviews 
consisted of 20 questions and required one 90-minute session. A group of semi-
structured, open-ended interview questions were constructed to address each of the 
research questions. The interview questions were categorized to answer the research 
questions. A parent who has a child with a disability reviewed the interview questions to 
ensure the validity of each question. The parent who reviewed the interview questions for 
validity was not a participant in the study. The feedback from the parent review resulted 
in the elimination of one question.  See Appendix C for the interview questions.  
The interviews captured the voice of the participants and gave them the 
opportunity to provide rich details about their experiences. The interview questions were 
aligned with the research questions (Appendix C). The data collected from the interviews 
will be stored on the researcher’s password- protected computer in a password-protected 
file. The data will also be stored on an encrypted USB device. The data will be destroyed  
3 years after the completion of the study by deleting it from all files.  
Data was reviewed and coding began after the initial interviews. The coding 




Procedures for Data Collection and Analysis 
The data collection in a narrative study needs to be analyzed for the story they tell 
(Creswell, 2014). The digital audio data was gathered using a recording device and 
handwritten note taking was transcribed and coded. After the interviews were conducted, 
an electronic program was used to transcribe each interview. Once interviews were 
transcribed, they were reviewed for accuracy. According to Corbin and Strauss (2015), 
“the coding process should be followed by creating data-driven codes identifying and 
outlining themes within convenient samples” (p. 11).  Each interviewee had one 
interview session. When required, follow-up questions were asked after the interviews 
were transcribed. Both axial and open coding methods were used to analyze each 
transcript. Open coding is a process of analyzing the transcripts and generating initial 
categories and identifying themes that emerge from the data. After open coding was 
complete axial coding was used to identify consistent themes and relationships within 
each interview related to the interview questions or research questions. To increase the 
strength of the study, intra-coder reliability, was conducted in addition to the researcher’s 
coding. A mentor assisted in validating the coding of the same data. The researcher’s 
mentor is a professor at a historically Black university and has a doctoral degree in 
education and communication from Syracuse University. The codes and transcripts were 
reviewed for consistency and/or agreement. 
Themes from interviews were compared to identify similarities and differences. A 
narrative description summarizing the results of the analyses was compiled and served as 
the foundation for the narratives presented in Chapter 4. A three-dimensional space 
approach was used involving analyzing data interaction (personal and social) situation 
 
40 
(place) and continuity (past, present, and future).  During and at the conclusion of the 
interviews, member checking was conducted to clarify any important points shared 
during the interview and to increase trustworthiness.  
The researcher used intra coding to verify the researcher’s coding system with 
fidelity. The researcher reviewed each of the transcripts identified the codes and noticed 
the codes had a distinctive sequential pattern.  The codes generated the categories and 
themes generated in Chapter 4.  After the interview process concluded, the data analysis 
began. The researcher wrote session notes to record any verbal emphasis, pauses, or 
changes in tone, plus expression of emotions.  
Summary 
Parents’ choice to select MM as the treatment plan for their children has been a 
topic of discussion for over a decade. The narrative data that the parents shared regarding 
how they formed a partnership with their K-12 public schools is important. It can be used 
to inform schools working to meet the health care needs of all students (Greener, 2018). 
This qualitative research study includes five research participants who partnered with 
their child’s school to implement a MM policy. Each participant answered three 
qualifying questions. Interviews were conducted virtually due to COVID-19. An in-depth 
interview format was used for this narrative study. A three dimensional space approach 
by Clandinin (2007) involving analyzing data for three elements: situation (physical 
places) interaction (personal and social), and continuity (past, present, and future). Open 
and axial coding was used to identify consistent themes and relationships within each 
interview related to the interview questions or research questions.  
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Themes from the interviews were compared to identify similarities and 
differences. This pioneer study is intended to be an informal guide to school district 
leaders and policy makers who are still grappling with the development of medical 
marijuana policies in their schools. The narrative study will provide a blueprint for 
parents, policy makers, and school district leaders to ensure all students have access to 
the treatment plans they need to produce positive student outcomes academically, 
emotionally, physically, and socially. 
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Chapter 4: Results 
The purpose of this qualitative narrative study was to explore parents’ perceptions 
of how MM policies are implemented in K-12 schools. Parents of students diagnosed 
with medical conditions such as ADHD and epilepsy are seeking MM as a treatment 
option. Their choice to have medical marijuana administered in public schools has 
created difficulties for state and federal lawmakers, students, school districts, and 
parents/guardians (Terrell, 2016). Thompson (2015) posited that MM benefits the lives of 
many people who suffer from life changing illnesses, such as multiple sclerosis (MS), 
epilepsy, autism, and glaucoma. In most cases, MM is prescribed and used in the form of 
a plant or an oil (cannabis oil), that the patient can ingest either through food or drink. 
While MM has been legal in some states for almost two decades, it is still illegal under 
federal law (Thompson, 2015). Parents’ demands for the use of MM is forcing school 
districts and lawmakers across the United States to tackle the issues regarding students 
who are prescribed medical marijuana (Jacobson, 2018).  
In 2019 the parent support group for children with epilepsy had roughly 1,450 
members, the parent group current has 1600 members.  As the group grows in numbers, 
so does the   number of parents across the country who turn to medical marijuana to treat 
their sick children, often after pharmaceutical remedies have failed. After years of 
attempting to keep marijuana cannabis out of schools, educators across the country now 
must address the issue of administering prescription MM to students (Terrell, 2016). 
When public school boards of education allow the administration of medical marijuana 
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on school grounds, they are violating federal law—even though marijuana use may be 
legal for medicinal purposes under state laws (DeNisco, 2016).  The participants in this 
study highlighted the process of obtaining state legislation for the use of MM and the 
challenges associated with school districts’ adopting a policy even after legislation was 
obtained. Some participants had to get court orders after the legislation was passed, in 
order to have school districts implement a MM policy to permit the administration of 
medical marijuana on school grounds. 
This chapter describes the findings based on data analysis of the responses of 
parents who have chosen medical marijuana as a treatment to address their children’s 
medical conditions. Direct quotes from each parent are included in this chapter to 
highlight their experiences, thoughts, and reflections, using authentic words and 
expressions. The findings from this study detail the steps that are recommended to 
develop and implement a MM policy in public schools.  
Parents who have selected MM as a treatment plan were interviewed and asked 
questions directly related to three research questions.  The research questions addressed 
three challenges identified in the literature. These challenges are: (a) parental experiences 
with policy implementation (Thompson, 2015); (b) children’s academic performance in 
school; and (c) social and emotional health after policy implementation (Terrell, 2016). 
Accordingly, the following research questions were constructed: 
1. Given current medical marijuana policies, how do parents describe their 
experiences implementing their children’s treatment plans? 
2. How does medical marijuana policy impact a parent’s perception of their 
child’s performance in school? 
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3. How do parents describe the implementation of existing medical marijuana 
policy on their child’s social and emotional development? 
Interview Questions 
Semi-structured, open-ended interview questions were constructed to address 
each of the research questions. (Appendix C). Each participant was asked the questions in 
the order listed on the table.  
Interview questions 1 and 2 were posed to explore the historical knowledge and 
reasons associated with the parents’ selection of medical marijuana as a treatment plan. 
The responses provided information for the development of school board policy. The 
open-ended, semi-structured style of questions allowed participants to respond with 
additional information about their rationale for choosing medical cannabis as a treatment 
plan. The structure of the questions ensured opportunities for additional and relevant 
follow-up questions to gain deeper understanding into the initial responses. Questions 3-5 
asked the participants to address events that occurred during the implementation process 
that might have caused them to question and/or doubt the existing MM policy. Interview 
questions 6-11 specifically addressed the impact the policy had on children’s academic 
functioning.  Interview questions 12-15 asked the participants to discuss the impact of the 
MM policy on their children’s social development. Interview questions 16-19 specifically 
asked the participants to address the emotional impact resulting from the MM policy. 
Interview question 20 provided participants the opportunity to reflect on the questions 






Interview Questions Aligned with Research Questions 
Research Questions Interview Questions 
1. Given current medical 
marijuana policies, how 
do parents describe their 
experiences implementing 
their children’s treatment 
plan? 
1.Why did you choose medical marijuana as a treatment plan for your 
child? 
2. How did your child’s school personnel react to your choice to use 
medical marijuana as a treatment plan? 
3.What, if any, positive and or negative experiences did you have while 
collaborating with the school to implement your child’s treatment plan? 
4. Can you share an experience during the process that left you feeling 
confident about your decision? 
5. Can you share an experience during the process that left you feeling 









2. How does MM policy 
impact parent’s 
perception of child’s 
performance? 
 
6. Have you had to postpone your preferred treatment plan of medical 
marijuana for your child?  How? Why? 
7. How did this shape your child’s academic performance? 
8. Do you view the current medical marijuana polices to be effective for 
children in K-12 schools? 
 
 
9. Have your child’s data on report cards increased or decreased due to the 
MM policy? 
10.Was there an improvement in academic outcomes due to 
implementation of MM policy? 
11. Can you share a moment or memory that stands out for you regarding 





3. How do parents 
describe the 
implementation of 
medical marijuana policy 





12.Has your child experienced any barriers to social development in 
school? 
13.Have behavioral concerns increased or decreased due MM policy? 
14. Do you feel your child’s social development has improved or declined 
due to the current medical marijuana policies in place in your child’s 
school? 
15. Do you feel your voice has been heard in the process regarding your 
child’s social development? 
16.What would you say to someone considering this treatment plan and 
journey with a school district?  
17. How has the choice of MM as a treatment plan affected your child’s 
emotional state? 
18. Can you share any success of challenges of your child’s emotional 
development due to the policy? 
19. Can you share an experience made you   reconsider your treatment plan 
because of your child’s emotional development? 







Five parents who had selected MM as a treatment plan and collaborated with 
schools to implement a policy were selected as participants for this study. The 
participants were identified through a parent group for students with disabilities. Each 
parent in the group had a child who was classified as educationally disabled under IDEA 
by their own school districts. Each parent’s name was substituted with a pseudonym, to 
protect the identity of the participant. Biographical information about each participant is 
below. Due to the global pandemic COVID-19 participants were interviewed virtually.  
Participant 1. Lena is the mother of two children. One of her children is 
classified as a student with a disability. Lena has selected MM as a treatment plan. Lena 
and her husband worked with their child’s school to implement a MM policy. Lena’s 
children attend a suburban school district. Lena is a recent widow who resides in New 
Jersey and was a stay-at-home mom for 18 years. Lena has recently returned to work 
after the passing of her husband who was the bread winner in the family. Lena’s two 
children attend New Jersey public schools. 
Participant 2. Carla is a married mother of four children. Carla selected medical 
marijuana as a treatment plan for her child. She worked with the school district to 
implement a policy.  Carla’s children attend a suburban school district. Two of her 
children are classified as students with disabilities. She is self-employed.  She and her 
family reside in Maryland. 
Participant 3. Gina is a single mother of three.  One child is classified as a 
student with a disability. She chose MM as the treatment plan for her child. Gina worked 
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with her child’s school to implement the MM policy.  Gina’s children attend a suburban 
school district. Gina resides in Maryland with her family and is self-employed. 
Participant 4. Rain is married with two children. Both children are classified as 
students with disabilities. She selected MM as a treatment plan. She worked with her 
school district to implement the medical marijuana policy. Rain’s children attend a 
suburban school district in Maryland. She is self-employed.  
Participant 5. Brett and Amy are a married couple who participated together. 
They have four children. One of their children is classified as a student with a disability. 
They selected MM as a treatment plan.  They worked with their school district to 
implement a medical marijuana plan. Their children attend a suburban school district in 
Colorado. Amy is employed in the medical field and Brett is self-employed.  
Data Analysis and Findings 
The data was analyzed by searching for themes from the participants’ comments. 
The findings are detailed below. Creswell and Creswell (2018) identified narrative 
sampling size guidelines for a narrative study as one to two cases. This study targeted 
five participants for the purposes of getting common themes of experiences and to obtain 
saturation. Every interview was recorded, At the completion of each interview, the 
recording was professionally transcribed by REV. Com transcription service. The 
researcher interpreted the data using a line-by-line color coding system. Several 
categories and themes emerged from the coded data.  Comments for each of the research 
questions were collected and transcribed. The data was considered in detail, preliminary 
characteristics were developed and identified. The coding scheme was developed using 
open coding, and axial coding. Selective codes were created by connecting and 
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consolidating axial codes. These codes were abstracted from the evidence produced from 
the data. Categories and themes became apparent from the analysis of the interview data 
and were constantly refined until a generalized pattern of the participants’ views were 
established. The interviews were rich and full of ideas, the most prominent categories 
were selected. Originally there were four research questions however, interview 
responses associated with Research Questions 3 and 4 often overlapped. Specifically, 
some participants merged social and emotional characteristics. These overlaps will be 
noted in the discussion section of this study. 
Research Question 1.  Data were collected to answer Research Question 1: 
Given current MM policies, how do parents describe their experiences implementing 
their children’s treatment plan? The participants were asked why they selected medical 
marijuana as a treatment plan. The participants were also asked to describe their school’s 
reaction to the treatment plan.  The parents were also asked to highlight any experiences 
that would provide insight into their rationale for selecting MM and describe how the 
support received from other parents encouraged them to advocate for implementation 
policies. Table 4.2 displays the codes, categories, and themes that emerged from the 
participant responses to the interview questions associated with Research Question 1. 
Five categories emerged from the coded data associated with the responses to 
questions regarding parents’ experiences with the implementation of medical marijuana 






Table 4.2  
Experiences with Policy Implementation     
 
Codes                                            Category                                   Theme 
unsuccessful doctors 
prescribe meds, increased 
medicine dosage.  
 
sleeping all day, did not 
stop seizures, feeling 
drugged, not able to 
complete daily task, alter  
 
personality, medical trials, 




Unsuccessful Results of 
Pharmaceutical Meds 
 












Unsuccessful Use of 
Pharmaceutical Medicines 
blueprints of other parents 
supporting court 
appearance 
legal protection,  
sharing information 






Parents supporting Parents 
 




testifying in court, legal 
fees, 134 days to sign a 
bill. 
 
proud moments, parents 
feeling victorious, 
conversations with the 









Categories. The responses to the interview questions were compiled into five 
emergent categories exploring the individual factors that were considered by parents.  
Table 4.3 displays the categories that emerged from the interview data and the frequency 
of each based on the responses to the interview questions. The X indicates the participant 





Experiences with Implementation Policy 
Category   Participants    Total 
 Lena Carla Gina Rain  Brett/Amy Total 
Unsuccessful 























































Victories                
 











                                     X X            X X 4 
 
Unsuccessful results of pharmaceutical medicine. The participants stated that 
their selection of medical marijuana as a treatment plan came after the unsuccessful use 
of prescribed pharmaceutical medicines.  All the participants defined pharmaceuticals as 
FDA approved medicines prescribed by a medical doctor.  All the participants referred to 
medical marijuana as medical cannabis. Three participants explained that medical 
cannabis is a term that has a positive association in the medical field and the term medical 
marijuana is often confused with recreational marijuana. Participants explained that 
although medical cannabis is recommended by a physician, a dosage cannot be specified 
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because the drug does not have federal approval for medical use. State law permits 
medical cannabis use. Doctors omitting dosage allows them to comply with both state 
and federal law.  
All the participants described pharmaceutical medicine as unsuccessful treatment 
for their children. The medicine did not provide adequate treatment of the diagnosed 
illness. The participants also indicated the treatment caused harmful side effects. 
For example, children would continue to have seizures while using the 
pharmaceutical medicine, in addition they would have adverse side effects. Lena said that 
the pharmaceutical medicines would make her child sicker. Lena stated. 
My daughter would continue to have several seizures a day while using 
pharmaceutical medicine. In addition to the seizures, my daughter would drool all 
day. She is non-verbal and is unable to communicate verbally . . . she would 
become so toxic that she would throw up for hours. There were times that she has 
not even been able to walk because she is that high, the adverse effects are so 
ironic because it bombed her out. Being high is the critic’s response to why 
medical cannabis is not the same for children, and my daughter was high on the 
pharma medicines. As her seizures continued, we have had days where she slept 
on end, and drooling, can you see a 16-year-old drooling, it is horrible, and my 
daughter does not drool. 
Carla stated that pharmaceutical medicine was prescribed in error: “my daughter 
was an infant when doctors began prescribing medicine and she was misdiagnosed seven 
times.”  Carla shared “before the age of 7 months my child had tried nine different 
medications.” Carla said that the medicines did not stop the seizures.   
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Gina discussed her son’s epilepsy: 
We would go to the emergency room every month for stitches from him falling 
while having seizures. The seizures did not cease while on the pharma meds.  My 
son was diagnosed with a rare type of epilepsy. For 16 months the doctors did 
nothing but give him a frequent cocktail of medicine that did not help stop the 
seizures and it did not help him at all.  
Rain described a similar experience with unsuccessful pharmaceutical medication. 
When her daughter was diagnosed the only treatments offered, were chemotherapy and 
immunotherapy.  “By age 8, neither of these therapies had proven successful for her 
daughter’s tumor, and there was a high reoccurrence rate after the treatment was used.”  
Rain also stated, “she would not allow the doctors to cut into her daughter’s head to 
remove the tumor because the first try was unsuccessful.” She states she refused the 
medical treatment because the doctors did not know what to do, “when I first brought her 
into the emergency room it literally took them an entire month even to figure out what to 
do.” 
Brett and Amy said the prescription pharma medicines made their child 
unrecognizable at times due to his erratic behavior. Amy stated, “the doctor’s continued 
to increase the of the medicine however, his seizures did not decline.” 
Side effects. The participants highlighted the side effects of prescribed medicines 
as another reason they selected medical marijuana as a treatment plan.  The side effects 
were harmful and affected the quality of life of the children. The side effects made 
children vomit multiple times a day. It made other children become aggressive and 
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unrecognizable to their parents. Other side effects included constant sleeping and 
incoherence.  
Lena stated, “my daughter did not respond to her own name and could barely lift 
her head up because she was so darn high.” Carla stated, “my life had become cooking 
using a ketogenic diet to help reduce the side effects of the medicine and doing dishes, 
my baby lost weight, he was unable to hold down any foods and he cried all the time.”  
Brett and Amy stated, “we did not recognize our son anymore; his attitude was of a 
totally different person. He was a sweet calm boy that turned into a raging ball of anger.” 
They shared a story about one night when their son completely lost his ability to speak 
due to the amount of medicine in his system. “At that point, we completely lost trust in 
pharmaceutical medicines.”  “Rain stated, “my daughter was on a liquid diet for 3 months 
because she was unable to keep in solids while on medication. It was a complete disaster 
and my entire family suffered watching her suffer.” 
Doctor’s limited experience with medical marijuana treatment. The participants 
each had a child who experienced many challenging symptoms due to seizures. The 
conditions varied from vomiting to speech loss. The participants explained that many of 
the conditions were unfamiliar and the doctors had little to no experience providing a 
medical treatment for the children. Doctors often over medicated children causing severe 
side effects including inebriation and inability to conduct simple tasks.  Doctors 
prescribed a cocktail of medicines that altered children’s personalities and did not treat 
the problem. The participants noted that many doctors said that they were not confident 
about the prescribed treatment plans even while the children were hospitalized or in their 
direct care. Rain said that,  
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The doctors had to call all around the world to find out how to treat my daughter’s 
tumor. It literally took them an entire month to figure out what type of tumor it 
was, and they had to call all over the world to find out how to treat it. I was 
uncomfortable with the medicines they were prescribing because they were so 
unsure, I just started staying up all night, because we had been given a very grim 
prognosis for her and I was determined, I am not going to bury my child. I could 
not sleep.  I was up reading publications I wanted to know what Phar Med showed 
and how I could find a cure for my daughter. 
 Lena stated: 
While my child was in Children’s Hospital in Philadelphia, she had one of the 
toughest cases to solve, we were at a dead end. I had to share information with the 
doctors regarding a woman in Chicago who was conducting a trial of treatments 
using medical cannabis in Philadelphia that might help my daughter. I am raising 
my hand at 3 a.m. in the morning asking why they did not pick us for that trial. 
We are right here in their backyard. I had to get on the phone and raise holy hell, 
and I guess the squeaky wheel gets the grease, because we were put on that 
medical trial that started with medical cannabis, before the trial, the doctors had 
no clue of what to do.   
Carla explained that, 
My daughter was in the pediatric intensive care unit, and the doctors did not know 
what to do, I was contacted by a parent who was using medical cannabis. I got the 
medicine sent to me over night and gave it to the doctors to administer to my 
daughter. The doctors said to me, good this baby deserves a chance. 
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Parent support. The participants highlighted the support provided by other 
parents who had selected medical cannabis as a treatment plan. The participants said the 
other parents were very helpful, providing resources on legal and medical issues. The 
participants said the support of other parents gave them the courage to select medical 
cannabis especially in the early years (1995) when it was still illegal to use or own 
cannabis. Parents provided access and connections to others who were in the process or 
had been through the process of selecting medical cannabis as a treatment plan. The 
parents shared resources and supported one another at court hearings and school board 
meetings.  They also gave emotional support for parents who were just beginning the 
process. The parental support was summarized by Carla:  
I distinctly remember receiving phone calls while we were at pediatric intensive 
care unit at John Hopkins from other parents encouraging me to use medical 
cannabis as a treatment plan. They were promising me I would not go to jail 
because I was very worried at first about the legal ramifications of giving it to my 
daughter. The parents also helped me navigate the legal system and provided 
advice as to which congressional representative to contact. They shared 
information regarding where to file petitions for the legal permission of continued 
use of medical cannabis for my daughter. In addition, they informed me of 
doctors to contact to get prescriptions for my child to become a registered medical 
cannabis user. 
Brett and Amy shared,  
We reached out to a parent who lived in our state that was already using 
Charlotte’s Web for her son. She was documenting her journey with her selection 
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of medical cannabis in a support group I was in. I asked her one day to share the 
information with me regarding how to purchase, what doctors to contact to get a 
script. I already had tons of information because I was following her story. Oh 
yeah! She also helped us prepare for our school board meeting and stayed up late 
at night to talk to us about the information we needed. 
Legal victories. Four participants credit the passage of state legislation as the 
primary driver of school policies. Parents worked hard for passage. They had to lobby for 
the support of local legislators, the support of legislation took months and at times years 
to obtain. After the legislation was approved it had to be signed by the governor, this 
process required additional wait time. When the legislation was finally adopted into law, 
parents in two states realized they had to obtain court orders to compel the school district 
to create a policy.  The parents who were interviewed shared the lengthy and costly 
process of advocating for state legislation and school board policies.  
Lena who resides in New Jersey reported “my husband filed over 17 petitions to 
the state before he was able to find legislators to help him. The legislators finally offered 
support; however, the governor of the state was against adopting the bill.” Lena reported 
it took the governor of her state 134 days before he was convinced and signed the bill.  
Brett and Amy live in Colorado, the first state to pass laws permitting medical 
cannabis. The state also permitted medical marijuana administration on school grounds 
by a school employee. They said: “We had to use the Rohrabacher Farr amendment” (i.e., 
the amendment prohibits the Justice Department from spending funds to interfere with 
the implementation of state medical cannabis laws).  Their state was one of the first to 
allow medical cannabis, however the schools did not comply with the state laws. Brett 
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and Amy had to go to court to obtain a court order to permit their son to use medical 
cannabis on school grounds after state legislation was passed. Brett and Amy also said 
neighboring school districts in the state implemented policies after state legislation was 
passed and a court order was not required for implementation.  
Carla said that her school district was not comfortable developing and 
implementing a policy, even after the state legislation was passed.  Carla stated she joined 
another parent who was already in the process of obtaining a court order to enforce the 
medical cannabis law in her school district. Carla shared “I teamed up with the parent and 
paid the legal refiling fee to have my own child added to the existing court order.” Carla 
shared that the process of obtaining state legislation in Maryland was lengthy, however 
she credits the overwhelming voting of yes to the legislation to an incident that occurred 
in the chamber. Carla recalled the incident:  
As I waited to testify for the legislation, my daughter had a seizure. Everyone was 
able to witness her illness firsthand. I had to administer her medical marijuana 
treatment right there in the room. I administered oral and topical medical cannabis 
and the seizure was over in about 45 seconds.  
Carla stated only one delegate voted against the legislation, everyone else voted yes.  
Carla shared this: 
I think a big part of it was they saw what went down. They saw the onset seizure, 
they heard the onset seizure, and they saw me stop it. When I got up to testify, I 
did not have to say much, my daughter was nonverbal at that time, but she spoke 
up for herself that day.  
Rain reported that,  
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We passed senate bill 181 in Delaware, before the law my daughter’s biggest 
concern was when and where she can get her medicine. A senator helped me get 
legislation passed after hearing my testimony, the senator joined me to get the 
legislation passed even at the disapproval of many community members. My 
family got the legislation passed by testifying before law makers and rallying 
other members of the community that had children with similar medical 
conditions. 
Rain reported:  
I knew a few parents said they were against it. So, we passed SB181 and it 
basically made cannabis legal on school grounds, a lot of parents were against it 
because they thought kids would be able to get cannabis, I would maybe give it to 
them, or something. I really do not know why they were against it.  
It took her school district almost 2 months to develop and institute policy after the 
legislation was passed. “We considered getting a court order, but the school district 
cooperated, and we did not have to obtain an order.” 
The categories connected to Research Question 1 emerged directly from the data 
associated with the responses to the interview questions, and they assisted in providing an 
understanding of the parents’ experiences with the implementation of medical marijuana 
policy in their children’s schools. The data were analyzed to uncover emergent themes 
and to provide a deeper understanding of the factors that were considered for this study. 
Themes. The analysis of the data from the interview responses produced three 
themes surrounding Research Question 1: unsuccessful use of pharmaceutical medicine, 
parents learning from other parents, and legislation. The three themes provide in-depth 
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insight into the important factors affecting the implementation of a medical marijuana 
policy in schools. This will be discussed further in Chapter 5. 
Unsuccessful results of pharmaceutical medicine. The unsuccessful use of 
pharmaceutical medicine emerged as one of the three major themes associated with 
Research Question 1. The participants highlighted the adverse effects pharmaceutical 
medicines produced in the children, preventing children from being fully conscious alert, 
and attentive. The side effects led parents to seek an alternate treatment plan (i.e., medical 
cannabis). Parents reported that schools displayed empathy for their child’s illness, 
however the schools needed to have the state sanction the use of medical marijuana in 
schools. 
Parents learning from other parents. This emerged as another theme that was 
related to Research Question 1. The direct support of other parents sharing resources, 
legal and educational information was an important factor in parents selecting medical 
cannabis as a treatment plan. The participants referenced the support of other parents in 
making decisions regarding their child’s treatment plan, achieving the legislation, and 
advocating for school board policies.  
Legislation. Legislation was the single most important theme. All participants 
stated legislation needed to be adopted before schools could develop policies.  Often 
these laws were named after the children identified in the petitions promoting the 
legislation. Once the legislation was passed, in some states medical marijuana policies 
could be developed and implemented in schools in a timely manner. In other states a 
court order had to be obtained before schools would develop and implement a policy. The 
emergent themes derived from the interview responses associated with Research 
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Question 1 helped in understanding the experiences of parents with medical marijuana 
implementation policy in schools. Research Question 2 sought to understand how 
medical marijuana policy impacts student’s academic achievement. 
Research Question 2. Data were collected to answer Research Question 2: How 
does the medical marijuana policy impact parent’s perception of child’s academic 
performance in school? Throughout the interviews, one theme emerged: the benefits of 
school board policy implementation. Table 4.4 displays codes, categories, and themes. 
Table 4.4 
Codes/Categories/Themes- Academic Impact of Medical Marijuana Policy 
Codes Category Theme 
Support of students, track 
data, change in academic 
performance, sustain 
behaviors, students 
interacting with peers, 
increased attendance. 
 
Teacher Reports Benefits of Policy Implementation  
Access to teacher directed 
lessons, group therapies, 







Listening to pleas, offering 
alternatives, proving grace 
to families, implementing 
policy 
 
Board of Education  
Focused on learning, 
writing complete sentences, 
talking using complete 
thoughts, improved 
attention, can complete 
assignments 






Table 4.5 displays four categories that emerged from the data as well as the participants 
who contributed to these categories. 
Table 4.5  




 Participants    Total 





















































       
 
Teacher reports.  Two out of five participants viewed data collection and reports 
to parents by teachers during the initial stages of the school’s medical marijuana policy 
implementation as an essential component to improving student’s academic development. 
Teacher created documents were used to chart the behaviors of the students. It was 
supplemented by written anecdotal notes of behaviors that recorded the frequency of 
academic improvements throughout the school day. These academic improvements 
included increased reading ability, improved handwriting, or improved outcomes on a 
test. The teacher reports also included social and emotional behaviors. How many times 
the child had positive interactions with peers? How frequently did the child need teacher 
prompts to transition from one task to another?  How long a child was able to 
independently attend to an academic task? How often did the child have outbursts in 
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class? The teacher reports provided information regarding how long the child was 
consistent with behaviors before a change occurred. They provided crucial information to 
parents helping to determine the cannabis dosage. 
 The teacher reports gave parents insight into their child’s performance in class.  
Lena stated “teachers were amazed how alert my daughter had become. She was able to 
follow single step directions and participate in teacher - directed lessons.”  Having 
teachers collect data was beneficial to Carla. The data displayed the benefits of the 
treatment on her child’s behavior. Her daughter had more peer interactions and was able 
to attend school full day.  Parents used the teacher reports to ensure students were getting 
appropriate dosages. The reports from teachers provided the parents information 
regarding academic performance, behaviors, peer relations, and how long the dosage 
sustained the student. 
Carla shared that the data from the teacher reports made it possible for her 
daughter to attend school full day. She was able to use the data to advocate for a full day 
school program for her child. Participants Brett and Amy shared that the teacher reports 
were used to help their son’s progress to classes that had more academic rigor.  The 
results of these interviews indicated that data collection allowed teachers to communicate 
the academic, and social behaviors they witnessed in the classroom to parents after the 
implementation of the policy. This information was critical for parents because it helped 
determine the dosage and efficacy of MM and it validated the need for a policy. 
CSE meetings. Committee on Special Education (CSE) meetings are held to 
develop individual evaluation plans for students with disabilities. These meetings provide 
an opportunity for parents, service providers, and teachers to collaborate and create 
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successful plans. According to all the participants in the study, these meetings offered the 
opportunity to discuss the medical treatment plan in detail. The meetings were beneficial 
according to Lena and Carla. They both described the meetings as a collective 
conversation that provided insight to the policy for all parties. The parents were able to 
share in-depth information regarding the treatment plans. The meetings also used data 
collected from the teachers to determine whether to increase or decrease special 
education services after the implementation of the policy. 
Rain stated, “the CSE meetings were a source of support especially because my 
husband worked at the school.” She shared “it felt like a family meeting, and  
everyone had my daughter’s best interest in mind when discussing the policy and her 
daughter’s needs.”  
Gina as well as Brett and Amy, all had positive experiences in the initial stages of 
policy implementation at CSE meetings. The initial meetings were collaborative, and 
everyone seemed to have the best interest of the children in the forefront. However, both 
families said that the tone of the meetings changed after the policy was implemented. 
Brett and Amy shared this: 
After policy implementation most of the interactions at the meeting were negative 
and it became a daunting progress. The school used the opportunity to share what 
they thought was in the best interest of our child. The school meetings became 
attack sessions and screaming matches without resolution.  
Gina stated “the school does not believe my son has an ability to learn and I am tired of 
fighting with them. CSE meetings are my least favorite thing to do on this earth.”  
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Board of education. The board of education is the group of individuals who 
govern the school district. The board of education adopts the policies and procedures that 
the district must follow. The board members are typically elected by the community with 
term limits. Three interview participants highlighted the board of education as helpful to 
policy implementation. “The board granted access for parents to come on to school 
grounds and administer the medicine to students, they began the policy right after we 
obtained legislation” stated Lena.  
During the interview, Lena stated, “members of the board of education came to 
my husband’s funeral to show support to him and all the work he put into passing 
legislation to get the policy implemented in the school.” She shared that her daughter was 
able to attend school in the regular academic setting and access direct teacher instruction 
instead of being home schooled.  Carla expressed her concerns to the board of education 
regarding administering medical marijuana on the school bus. She stated, “they are 
working together to create a policy for the school bus. My daughter needs her treatment 
plan available on the bus in case she has a seizure.”   
Rain described the relationship between her family and the board of education as 
supportive and encouraging. Rain stated,  
They were receptive to our child’s need and listened every time we had a concern. 
I believe the board’s support has transferred to my daughter’s classroom 
performance. She is more focused on her studies knowing she has the support of 
the board education. 
Student performance. Student performance was highlighted by four participants 
as a positive outcome of the medical marijuana policy implementation. Achievement was 
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measured by participants based upon individual levels of performance. Some participants 
expressed student performance using grades. Other participants identified student 
performance in terms of reading and reciting the alphabet and sight words.  A few 
participants expressed student performance as social self-awareness. 
Rain described her daughter’s performance as attentive and focused. It resulted in 
her zeroing in on the work because she also wanted to prove the treatment plan worked. 
Rain shared “my daughter would strive to get A’s because it made my daughter happy.” 
She shared her daughter’s grades got better each year and her daughter’s grades became 
the best thing about school.  
Gina shared a positive story about her son’s improved handwriting. Gina stated 
“my son’s previous handwriting was illegible. His schoolwork was unclear. His 
performance has improved. His writing is legible. We can hang his writing on the wall 
and read it.” 
Brett and Amy highlighted their son’s technical ability. Brett and Amy stated this: 
He began transferring knowledge learned in school to home projects. He would 
order 3D printers from Amazon, read the directions, and construct the printers, we 
were astonished to learn he was able to order items off the Internet and were 
fascinated by his ability to read the instructions and build the printers.  
Carla stated,  
We went from our vocalizations increased from our vowels, now we have vowel 
consonant combinations, we have inflection, we have tonal changes. We get sad 
when we run and we fall and we crash, but we did not realize that happened 
before. The physical awareness, the social interactions. She realized we have a 
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dog. The dog, she can seek comfort in the dog, it is not just a ball of fur that I can 
climb over, I can cuddle it. I can caress it. She interacts with herself in the mirror 
somewhat, she is looking at herself in the mirror as opposed to looking through 
herself in the mirror. By typical parents’ standards, those are not huge things. But 
in our world, that is the sky is blowing up and we are just over the moon with the 
cognitive progress she has made since the policy implementation. 
Benefits of policy. All of the participants considered the actual medical marijuana 
policy implementation a victory. The participants highlighted the policy as a tremendous 
positive step in their child’s treatment plan. The participants felt that it was a reward for 
the tremendous amount of time and effort put forth to obtain the legislation required 
before the boards of education could consider implementation. The policy permitted 
children to remain in school full days to access direct teacher instruction; leading to 
increased exposure to curriculum and increased academic success. The policy afforded 
children same age peer interactions and the opportunity to learn from peers. The policy 
provided outlets for children who were non-verbal to communicate using assistive 
technology. The policy gave children access to the medicine they needed during the 
school day. As illustrated in Table 4.5, data collection, CSE meetings, boards of 
education, and student performance were essential categories to the theme of benefits of 
medical marijuana policy.  
Research Questions 3. Data were collected to answer Research Question 3: How 
do parents describe the implementation of medical marijuana policy on their child’s 
social and emotional development? The study allowed the researcher to understand the 
participant’s experiences with medical marijuana policy and its effects on their child’s 
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social and emotional development. Initially interview questions separated social and 
emotional development.  However, the participants’ responses intertwined the social and 
emotional developments into one theme with five categories.  
As the interviews progressed, narratives were shared that demonstrated similar 
experiences. Those shared experiences were coded into categories and resulted in the 
theme labeled challenges of policy implementation. Table 4.6 displays the codes, 
categories, and themes that emerged for Research Questions 3.  Table 4.7 illustrates the 
participant responses to each category for qualifying characteristics – social and 
emotional effects of medical cannabis policy implementation.  
Table 4.6 
Codes, Categories, Themes- Qualifying Characteristics- Social and Emotional Effects  
Codes  Category Theme 
Refuse to administer medicines, testing 








Parents administer, no administration on 





Feeling isolated, limited sports, cannot 





Negative reactions, putting up posters against 






Hurtful post, called a drug dealer, calling 
child protective services,  








Frequency Chart of Participant Responses- Implementation Policy on Social and 
Emotional Development 
 
Category Participants     Total 
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Outed to Community 
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Note. The table illustrates five categories that emerged during the interview of all 
participants for Research questions 3. 
 
School nurses. School nurses are employed to address students’ medical needs 
during the school day. The medical needs of students range from a band aid for a bruise 
to administering medication for medical conditions as prescribed by a physician. Findings 
in this study revealed three out of five participants identified school nurses as a challenge 
to medical marijuana school implementation policy. Lena described the nurse’s 
opposition to administering medical marijuana treatment to her daughter as disheartening.  
Lena stated,  
The nurses stated they were not licensed to administer the drug. I tried to add the 
nurses to the legislation to legally require them to administer the treatment plan. I 
was unable to add the wording to the legislation.  
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Carla expressed it was essential to have the nurses administer the treatment to 
students. Carla stated, 
There are two nurses that testified against the legislation. At that time, the bill had 
stated that nurses would administer, and we changed the wording of the bill to 
school staff would administer. In my state there is a law, a clause, or something 
that states if a nurse administers medical cannabis to a medical cannabis patient, 
she cannot be stripped of her licensure. So, nurses were already protected. But 
some of them were nervous because they are the front-line medical administrator 
within the school system.  I did not want to put anyone in a position that they felt 
everything they worked for in their life, their degree, their clinical certifications 
could be at risk. That is one reason we changed the wording of the legislation to 
staff, the other reason that we changed it to staff is access on a school bus. My 
daughter is going to need a one-to-one aide, she is going to have a one-to-one 
with her, but that individual does not have to be a nurse. But that individual must 
be able to administer cannabis so the fact that any school personnel can 
administer it, as opposed to just limited it to nursing staff, I think was an 
important part of the bill. 
In another statement, Brett and Amy acknowledged:  
All the schools within our county share 30 nurses. So, one nurse travels between 
all those schools and whatnot. Nurses are shared within the elementary, middle, 
and high schools. The nurses do not actually do any administering of any 
medications. 
Amy stated:  
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We did not know nurses were not administering medicines, we found this out 
during the question process in the legal hearing. The medicine process is 
delegated to the front office people at the school. They are non-licensed; I believe 
this is the school’s way of getting around how the medications are being 
administered. The schools can say to parents, if something happens, you elected 
to have the medicine administered by a staff member. It is almost like it is a way 
for the nurse not to get in trouble.   
Limited policy. All participants addressed the major barrier of policies that require 
them to travel to campus every day to administer the treatment.  Parents interviewed had 
flexible schedules that permitted them to go to campus daily. However, they all shared 
the feeling that it was inconvenient.  Additionally, some policies allowed MM to be 
stored in the nurse’s office along with other medical treatments. Other policies required 
that the medical cannabis be brought to school grounds by the individual administering 
the treatment to the child.  Lena stated,  
The policy was fine when I was a stay-at-home mother, I was able to set my 
schedule around her treatments and I was able to drive 30 minutes each way to 
campus daily, pull her out of class, and administer the medicine. After the passing 
of my husband, I had to become employed, and I am unable to go to campus to 
administer the treatment anymore.   
Carla stated,  
I am self-employed so I can go to campus every day, but it impacts my other 
children’s activities and my ability to complete many tasks throughout the day. 
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My older children have games and activities that I often miss because I must 
make my daughter’s treatment a priority.  
Gina, who is self-employed stated,  
I can go to campus to administer the treatment; it has been difficult to adhere to 
the current policy; that is why I am transferring my child to a private school that 
will allow on-campus administering of his treatment plan by a staff member.  
Rain, who is self-employed stated:  
I must pause my work schedule and drive to the school campus to administer her 
medication every day. I would go to the school and check her out. I would have to 
check her out of school and then walk her off school property where I would have 
my car parked, give her the medicine, and then walk her back to school. The 
whole thing would take about 45 minutes. Normally, if you take a kid out of 
school, they mark that time off, but her school was supportive, and even though I 
would mark her out, they never counted any of that time against her.  
Rain’s daughter was attending the middle school that was a 12-minute ride from 
home in each direction. Rain’s daughter would be attending a high school that is 35 
minutes away in each direction.  She expressed concerns about the increased distance 
becoming a challenge.  Brett and Amy shared that Brett was self-employed and went to 
campus to administer the medication to their son. Amy worked and her schedule did not 
permit her the flexibility to go to the school daily to administer the treatment plan to their 






I am frustrated with the current policy; I went to the school accompanied by the 
sheriff and placed the medical cannabis on the principal’s desk and informed him 
he was violating my son’s rights and impacting his social and emotional 
development by having him singled out to take his medicine every day.  
Brett was visibly upset during the interview regarding the policy. Brett shared.  
I am frustrated with the current policy. I am suing the principal and the 
superintendent; I have a legal right to leave my son’s medicine on campus and my 
son has a legal right to have his medicine administered to him like every other 
child in the school building.  
The parents shared their frustrations as taxpayers and community members in the 
district. The parents were all initially happy, because after legislation passed a board of 
education policy was developed and implemented. However, three participants said that 
they were seeking to have the policy reviewed to include administration by school 
personnel. 
Social isolation. Two participants reported that their children felt isolated and 
different from peers because they had to leave class every day and report to their parents 
to receive their medicine. Rain stated,  
My daughter wants to go to the nurse like the children with asthma or other 
illness, my daughter is isolated on sport teams and is afraid her peers will tease 
her. My daughter told me classmates would see me out the window and they 
would either wave or they would be like why do you go outside the school all the 
time. It was the same time every day, I would take her out of one class because 
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that was the time I had scheduled to come and I never wanted to disrupt her lunch 
because that is her social time, so I would try to get there at the end of a class or 
try to get the timing right.    
Also, Rain shared that her daughter has no visible signs of a disability and lives a 
typical teenage life, that includes friends, outings, and social activities.  “My daughter is 
at the age where she is conscious of her image and the thoughts of her peers’ matter to 
her.”   
Brett and Amy revealed that,  
Our son is not happy when we arrive daily, he feels singled out, often seeks the 
support of his older siblings in the school. He is a high school boy with peers who 
respect him. He plays sports and does not like to be singled-out, however he has 
plenty of friends and he is very busy. He is involved in the state sport of Colorado 
and he is highly known. We just had a book written about him and his story was 
written in the New York Times, because he has overcome all the things he has, 
his friends are far and wide. It is amazing, the support he has and the people who 
love him. He has been an incredible example of perseverance in a situation where 
most people would have folded up because this is about the ability of having 
strength to stand up to something that is so big and has so much power, it is 
almost a bully scenario where they are trying to wear you down and hope you just 
quit.  
As a final point, Brett expressed that they were currently suing the school to 




Outed to the community. Two participants addressed what they called being 
“outed to the community” this is when the families go public about their selection of a 
medical marijuana treatment plan.  Participants had to engage in a legal process to obtain 
the legislation required for schools to implement a medical marijuana policy. When 
participants began the legal process, it was reported in the local newspapers. The names 
of the participants were listed in public court documents. The information was also 
included in the school board minutes after the legislation was passed, the policy created 
and approved.   As a result, the community was aware of the choice of treatment plan and 
began vocally expressing their concerns about administering cannabis on school grounds. 
Rain stated after she was “outed;” her family received criticism from the 
neighbors and others in the community. She described her daughter’s experiences as 
follows:  
My daughter’s face was used in health classes on anti-drug posters, she was asked 
by peers to buy or sell drugs to them, my daughter became shy and withdrawn for 
a lengthy amount of time. She was quiet and afraid to talk to peers. She did not 
know who to talk to in school. My daughter is nationally recognized for her 
medical cannabis advocacy and my daughter does not trust the intentions of many 
of her peers.  
Over the course of the interview, Rain shared that,  
I was in our community grocery store with my daughter and a person in the store 
screamed at her across the store yelling “You are a drug dealer! You are a horrible 
parent for giving your child drugs! You should be put in jail!  
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She expressed that she and her daughter were emotionally scarred for a long time 
following the incident.  Brett and Amy shared,  
Our son has friends, and he stays busy, he is highly conscious of how people 
respond to him. He often feels he must tackle adults who are upset because of his 
medical treatment. A child should not be afraid to interact with adults because of 
their medical treatment. We assure him we will address all adults on his behalf. 
Social media. One participant associated social media as a deterrent to their 
child’s social and emotional development.  Social media has become an outlet for 
unwarranted opinions and bullying at times.  Social media platforms can be very hurtful 
to adults and more damaging for children. Rain stated her child was subject to negative 
comments regarding the policy on social media platforms. She highlighted the comments 
on social media as a form of bullying. It caused her daughter to have anxiety, and loss of 
some peer relationships. Rain stated,  
I had to file a cease-and-desist letter to the neighboring school district because 
they were using images of my daughter in their curriculum. They were posting 
images of my daughter on social media and around their schools. The images 
portrayed my daughter as a druggie and cautioned students to stay away from her. 
I had my lawyer immediately serve the school district the letters to stop but the 
damage was done.  
Rain shared that her daughter was bombarded with the images on her social media 
platforms and many of her daughter’s friends shared the photo and images with her 
daughter. She stated “my daughter developed anxiety and it became difficult for her to 
trust peers. She lost confidence and herself and had to attend therapy.”  
 
76 
Summary of Results 
This study used a qualitative research narrative study to obtain in-depth 
perspectives of parent’s experiences with medical marijuana implementation policies in 
K-12 schools. A narrative approach was used to understand attitudes, beliefs, perceptions, 
thoughts, and experiences. The qualitative research method, using semi-structured 
interviews allowed the collection of data. The open coding process resulted in a vast 
amount of information outlining various coded characteristics that supported the personal 
narratives and experiences by the interview participants. The categories which emerged 
from this coding process were aligned with the three research questions. The codes, 
categories, and themes that emerged from the interviews correspond to the experiences 
connected to participants’ perceptions.  
The emerging themes for Research Question 1were: a) unsuccessful use of 
pharmaceutical medicine, b) parents learning from other parents, and c) legislation. The 
responses to the interview to Research Question 2 produced four categories and one 
theme – the benefits of policy implementation. Responses to Research Question 3 also 
produced one theme Challenges of MM policy.  It emerged from four categories. Lastly, 
the findings described the order of events leading to the implementation of cannabis 
policy in schools. It begins with unsuccessful experiences with prescribed pharmaceutical 
medicine, followed by the choice of medical marijuana as a treatment plan, and the most 
significant finding, the need to pass state legislation before a school board policy can be 
developed and implemented in some districts. This is in addition to the need to obtain a 
court order for implementation after state legislation is passed other districts. Another 
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theme that emerged were benefits of current medical marijuana policy. The last theme 






Chapter 5: Discussion 
Introduction 
This chapter provides a discussion of the implications of this research. It also 
describes the limitations of the study and provides recommendations for further research.  
Finally, it summarizes the research and offers a conclusion.  The research explores the 
experiences of parents of students diagnosed with medical conditions such as ADHD and 
epilepsy who have chosen MM as a treatment option. Their choice to have medical 
marijuana administered in public schools has created difficulties for state and federal 
lawmakers, students, school districts, and parents/guardians (Terrell, 2016). Thompson 
(2015) posited that medical marijuana benefits the lives of many people who suffer from 
life changing illnesses, such as multiple sclerosis, epilepsy, autism, and glaucoma. 
Parents who have selected MM treatment are requiring schools to allow the 
administration of the medical marijuana treatment during the school day. The students 
who require a midday dosage of MM require a school policy to receive the treatment. 
Medical marijuana policy is rapidly evolving in the United States. Marijuana sales 
are legal and regulated in some jurisdictions, and the use of the drug for medicinal 
purposes is permitted in many others. Parents of children with epilepsy and ADHD have 
explored MM and CBD as treatments. In most cases, MM is prescribed and used in the 
form of a plant or an oil, that the patient can ingest either through food or drink.  
 Parents and school districts across the country face similar problems as more 
people turn to MM to treat their sick children, often after pharmaceutical remedies have 
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failed. State governments must decide whether to approve a law that would allow the 
administering of MM to kids at school, setting up a potential conflict with the federal 
government.  At risk is potential criminal liability as well as the potential loss of federal 
funds, including money for school breakfasts and lunches for low-income students, for 
violations of the federal drug-free school zone mandate. 
Of the 33 states and Washington, D.C., that have legalized medical marijuana, at 
least seven have enacted laws or regulations that allow students to use it on school 
grounds, in part because doing so could risk their federal funding. So far, the federal 
government has not penalized any of the seven states. 
New Jersey, Maryland, Delaware, and Colorado permit parents to give their child 
non-smokable medical marijuana at school. This summer, Colorado expanded its law to 
allow school staff to administer the medication. Washington and Florida allow school 
districts to decide for themselves whether to allow the drug on campuses. Maine 
expanded state regulations to permit MM administration at school. However, because it 
is still illegal under federal law a doctor may prescribe the drug and recommend a dosage, 
an exact dose cannot be prescribed. 
 Nationwide, families have been negatively affected by their children’s school’s 
refusal to allow staff to administer prescribed MM to students (Jacobson, 2018). As a 
result, students are prohibited from receiving their prescribed medication while receiving 
a public education. Some schools have implemented policies that require students to go 
home in the middle of the school day to take their medication, meaning, these students 
often complete only a half day at school. When students are denied their prescribed 
medication, or they must leave in the middle of the school day to take their medication, 
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their daily routine is disrupted, and their academics and social-emotional development 
suffer (DeNisco, 2016). 
Parents’ choice to select MM as the treatment for their children has been a topic 
of discussion for over a decade. This study validates the need for school district leaders 
and policy makers to include parent voice in the development of medical marijuana 
policies in schools, to ensure that all students have access to their prescribed treatment 
plans. This study highlights the experiences of parents who have selected medical 
marijuana for their children who are diagnosed with epilepsy and/or ADHD. Children 
who have been diagnosed with these conditions have benefitted from the use of medical 
marijuana as a treatment (Wiederman, 2017). This study explored the implementation of 
MM treatment plans in New Jersey, Maryland, and Colorado school districts and parent’s 
perspectives on their children’s academic, social, and emotional functioning (Burke & 
Goldman, 2015).    
 The significance of this study is the data it provides to inform medical marijuana 
policy decisions both at the state and school level. The experiences of parents can provide 
guidance to school districts to ensure policies are created with an equitable template to 
allow students greater access to K-12 instruction and school sponsored recreational 
activities. This study can inform parents of the inherent conflict between federal and state 
law. Some state law permits the use of MM with a doctor’s prescription. Other state 
legislation says medical marijuana is legal for both medicinal and recreational purposes. 
Federal law states under the Drug Free School and Community Act (enacted 1989) 
marijuana use strictly forbidden on school grounds (Norwood, 2018). 
The study answered the following research questions: 
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1. Given current medical marijuana policies, how do parents describe their experiences 
implementing their children’s treatment plans? 
2.How does medical marijuana policy impact parents’ perceptions of child’s performance 
in school?? 
3.How do parents describe the implementation of existing medical marijuana policy on 
their child’s social and emotional development? 
The five participants in this study were all parents of children classified with a 
disability, who collaborated with school districts to create a medical marijuana policy. 
The population for this study consisted of the parents of five children who attend New 
Jersey, Maryland, and Colorado schools and have chosen treatment plans for their 
children. New Jersey, Maryland, and Colorado were the chosen locations because they 
have legalized the use of medical marijuana. These states also specifically permitted the 
administration of medical marijuana in K-12 public schools. The following questions 
were qualifiers for participation in the study: 
1.Do you have a child or children of K-12 school age?  
2.Have you selected medical marijuana as a treatment plan for your child? 
3.Do you have children who attend school in New Jersey, Maryland, or Colorado? 
After the interviews were conducted, an electronic program was used to transcribe each 
interview. Once the interviews were transcribed, they were read for accuracy before 
being analyzed. To analyze the data detail, preliminary characteristics were developed 
and identified. The coding scheme was developed using open coding, and axial coding. 
Selective codes were created by connecting and consolidating axial codes. These codes 
were abstracted from the evidence produced from the data. Categories and themes 
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became apparent from the analysis of the interview data and were constantly refined until 
a generalized pattern of the participants’ views were established. The interviews were 
rich and full of ideas, the most prominent categories were selected. Originally there were 
four research questions however, interview responses associated with Research Questions 
3 and 4 often overlapped. Specifically, some participants merged social and emotional 
characteristics. The overlaps will be discussed in this section. 
The results of this study reveal five major themes based on responses to the three 
research questions.  The themes that emerged were a) unsuccessful use of pharmaceutical 
drugs, b) parents educating parents, c) legislation, d.) school policy benefits, and e) 
school policy challenges. 
 Unsuccessful results from pharmaceutical medicines – parents shared their 
experiences with pharmaceutical medicines’ adverse effects on their children and how 
those adverse effects led to them to seek alternative medical treatment plans.  The 
findings associated with this theme included pharmaceutical medicines unable to provide 
a cure, physicians’ uncertainty regarding the course of treatment and their lack of 
experience with MM treatment. The parents outlined the effects of prescribed 
pharmaceutical medicines on their child’s academic, social, and emotional development. 
The participants also spoke of children acting “high”, experiencing personality and 
behaviors changes and “always sleeping.” 
Parents educating parents - parents turn to other parents seeking knowledge and 
support to begin the journey of selecting MM treatment.  The findings associated with 
this theme include parents support of each other, parents outlining a blueprint of success 
with obtaining legislation and school policy.  
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 Legislation - parents seeking legislation to get MM administration policies in 
schools. The findings associated with this theme describe the need for parent petitions to 
policy makers for legislation to allow MM administration policies in schools. The finding 
also shared the inconsistent federal and state laws that create a barrier for parents to 
obtain policy implementation.  
School policy benefits -the success associated with school medical cannabis 
policies is substantial. The findings associated with this theme include policy 
implementation victories, schools adopting a policy, teachers, and school staff supporting 
the parents’ choice. Students having the ability to participate in a full school day resulting 
in increased social interactions with peers.  
School policy challenges - the barriers that exist with the current policies are 
highlighted in this theme. The findings include parents coming to school every day to 
administer the treatment to their children. School nurses who petition against 
administering the medicine to students. Students who feel isolated from friends because 
they are singled out while receiving their medical treatment from their parent (i.e. unable 
to go to the nurse’s office to receive their treatment like their peers). A key finding in this 
theme is children being targeted as drug users or being shamed in anti-drug campaigns. 
Implications of Findings 
The findings of this study are significant because they highlight the voices of 
parents of children receiving MM treatment. These findings add to the ongoing 
conversations about administering MM in K-12 schools.  
For parents, this study provides narratives about experiences working with school 
district’s medical cannabis policies. It demonstrates the need for state legislation as a 
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precursor to developing a school board policy. This is a lengthy process.  For example, 
one participant said it took 134 days to have the legislation approved and signed by the 
state governor. This legislation wait time was in addition to the time expended advocating 
for support from local officials.  Other findings attest to the need for support from other 
parents. They provide vital information and valuable resources. The findings also 
describe some of the challenges of advocating for state legislation to implement a MM 
school policy.  These include possible community bullying and the potentially negative 
impact on students’ academic, social, and emotional development. This information 
should be helpful to parents and school officials when making informed choices 
regarding medical cannabis policy implementation in schools. 
For school policy makers, this study should help to inform the process of 
developing a medical cannabis administration policy. The study details the experiences of 
parents and highlights the benefits and challenges of medical cannabis policy 
implementation.  The study presents narratives that describe parents’ experiences and 
includes examples of the continuous support parents received from the teachers and 
professionals who work directly with their children. The support in the classroom 
provided valuable academic, social, and emotional performance data that was helpful in 
determining the correct dosage. A major restriction of these school policies was the 
provision that required parents to personally administer the treatment to students.  This is 
an area that needs more consideration. The resistance of school nurses who testified and 
refused to administer the MM treatment plan also need to be discussed and addressed. 
Hopefully, the findings from this study will be the catalyst for future studies centered on 
the implementation of medical cannabis policies in K-12 schools. 
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For parents, the findings demonstrate the “tug of war” between federal and state 
laws. Federal law continues to categorize medical marijuana as a classified drug and does 
not recognize it as a medical cure. Additionally, it precludes administration or possession 
on school grounds.  Currently, 33 states and Washington D.C. have legalized medical 
marijuana use.  New Jersey, Maryland, and Colorado, in violation of federal mandates, 
have allowed MM use on school grounds for treatment of students. State legislation and 
doctor’s prescriptions provide hope to parents regarding MM school policy 
implementation. However, this hope is dimmed when school board policies are limited 
and often require a court order for implementation. 
Major finding 1. Parents turned to medical cannabis only after traditional FDA 
approved medicines failed to help their children.  The side effects from traditional FDA 
approved medicines made it difficult for children to perform daily academic and social 
The participants used language such as “zombie” to describe children who were not alert 
and unable to conduct basic daily tasks. The participants described students as being 
“high” and sleepy at times. The side effects caused sickness like vomiting and mood 
changes in the children. The participants noted children were not able to participate in 
school due to incoherence.  They were unable to follow simple commands. The 
participants highlighted the stress the medication caused on the entire family.    
These side effects from FDA approved medicines described by parents are 
outlined in the literature which promotes the use of medical cannabis after 
pharmaceutical methods have been unsuccessful (Carbone, 2018). Parents reported 
improved quality of life and a sense of normalcy after using medical marijuana 
(Klumpers et al., 2012).  In future studies when the topic of medical cannabis is 
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discussed, it will be necessary to emphasize the side effects of prescribed FDA approved 
drugs to ensure it is understood that all drugs have positive and negative side effects. 
Major finding 2.  State legislation is needed before a board of education policy 
will be considered for K-12 public schools. DeNisco (2016) stated that as states continue 
to pass legislation to legalize medical marijuana, parents are trapped in a political “tug of 
war” between federal and state laws.  This finding was unexpected.  Prior to the 
interviews, the researcher expected to gather rich information regarding policy 
development and the experiences associated with a parent-school partnership resulting in 
the creation of a medical cannabis policy in K-12 schools. The findings from this study 
reveal state legislation is the gateway to the development of a school medical cannabis 
policy. The participants shared experiences about the process needed to advocate for and 
pass the necessary state legislation. The participants’ experiences included extensive 
paperwork and funding associated with developing, advocating, and passing the 
legislation required before the schools would even begin to discuss medical cannabis 
policies.  Participants state that they felt victorious when the medical cannabis state 
legislation was approved.  It led to the creation of a school district policy. When asked if 
the process of policy development was collaborative, participants answered “no.”  
 The researcher concurs with this finding: legislation must be in place before a 
school policy can be developed. The parents needed to be resilient to continue to fight for 
state legislation.  The parent participants outlined the arduous process it took to pass 
legislation. One participant described an episode when her child had a seizure in the 
middle of a legislative hearing.  She administered the medical cannabis treatment in the 
hearing room, demonstrating its benefits and the need for medical cannabis policies in 
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schools.  The participant believes that incident led to the overwhelmingly positive 
legislative response resulting in the passage of a medical cannabis bill in her state.  This 
incident reinforces the need for additional studies to help doctors, policy makers, and 
school districts unify.  
Major finding 3. There are many benefits and challenges of policy 
implementation. The themes of school policy benefits and school policy challenges were 
derived from responses to the last research question. The theme entailed the categories of 
school board members, peer interactions, nurses, and community response and 
interactions.  The categories presented the largest victories and challenges for 
participants. All participants spoke about the excitement they experienced when the 
school board finally adopted a policy to allow the administration of medical cannabis on 
school grounds. The policy allows students to remain full time in a school community 
with uninterrupted academic and social opportunities.  
This finding is connected to the theme that reflects the challenges presented by 
school nurses who testified against the policy and refused to administer the treatment to 
students.  This resulted in policies that were adopted requiring parents and caretakers to 
go to school to administer the medicine daily. One participant noted going to campus was 
easy when she was a stay-at-home parent, however after the passing of her husband she 
had to work. She was no longer able to administer the medicine. Another challenge arose 
when children were labeled as drug users by peers and community members. A 
participant explained that her daughter experienced rising anxiety because of her fear to 
be known as “the girl who used medical cannabis.” The participant also identified the 
isolation her daughter felt every time she had to leave the classroom to receive her 
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medical cannabis treatment from her mother instead of going to the nurse like her peers. 
Her mother who is a business owner can come to school and administer the treatment 
plan because she was able to create her own schedule and block out the time. 
Unexpected finding 1. Research participants identified as self-employed.  The 
self-employment offered the freedom to create their own schedules. This allowed for 
compliance with medical cannabis school policies that required parents to administer the 
treatment. Four out of six participants identified as business owners. There were no 
questions asked about the type of business; these items were disclosed as part of the 
conversations. The business owners shared the information to explain how they were able 
to comply with school policies that required them to go to school daily to administer the 
medical cannabis treatment plan. The participants shared that although the policy was 
inconvenient it was something they could manage. 
Unexpected finding 2. Research participants shared the joy they experienced 
after obtaining state legislation for the implementation of a medical marijuana policy. In 
some states that joy was short- lived due to the federal law that classifies medical 
marijuana as a schedule 1 drug. Participants had to obtain a court order to enforce the 
state legislation in their school districts. The disconnect between federal and state law 
poses a disconnect on the school level. Many school officials want to follow the state law 
and help children to maximize their academic, social, and emotional experiences in 




This section addresses the limitations and delimitations of this study. The 
limitations are influences that the researcher cannot control. The delimitations are 
conditions that are controlled and influence the design and outcome of the study. 
One limitation is that all the participants in the study have a degree of connection 
to the researcher. They are known by someone who referred them to the researcher. An 
individual was referred by someone in a parent group or someone connected to 
legislation involving medical cannabis policies in the K-12 public schools. This 
demonstrates a degree of self-interest by the participants to share their journey with the 
researcher. Another limitation is parents participating in this study are all from suburban 
school districts. 
Another limitation was the sample size which impacts the ability to generalize the 
findings.  The occupations and the resources of participants produced similar narratives. 
This limitation suggests that individuals with resources will have similar narratives. 
Therefore, the findings cannot be generalized to all parents who choose medical cannabis 
as a treatment.  There are additional factors that impact the implementation of medical 
marijuana policies in K-12 schools.  
A delimitation of this study required that the participants be parents who selected 
medical cannabis as a treatment plan for their children.  This requirement was necessary 
to address research questions and to explore the perceptions of parents with the 
implementation of medical cannabis policies in K-12 schools. The researcher wanted to 
explore parent’s experiences when collaborating with their children’s schools.  A careful 
and collaboratively developed medical cannabis school policy will promote academic 
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success and foster healthy social and emotional experiences leading to positive student 
outcomes. 
Recommendations 
Three recommendations for future practice involving parents’ experiences with 
medical cannabis implementation policy in K-12 schools are outlined in this section.  The 
recommendations, based on the findings, offer considerations for addressing parents who 
are employed and do not have the needed resources as well as strategies to address the 
resistance of school nurses. 
Recommendation 1. The participants in this study live in suburban towns and 
their children attend suburban school districts. These participants have the financial 
resources to pay the legal fees to influence state legislation. Eighty percent of the 
participants are also self-employed. The flexibility of self-employment allows them the 
time to go to school and administer the treatment in compliance with current policies. 
Future studies should include participants from urban and inner-city school districts. The 
study could target a sample of parents who do not have the financial resources or the 
schedule flexibility to adhere to the current school implementation policies. A future 
study could also address the successes and barriers of implementing a policy in urban 
school districts – how parents collaborate with the school board, school leadership, and 
schoolteachers. The study should include a description of the parental resources that 
would be available to influence state legislation. Parents who live in urban school 
districts face a unique set of challenges (McNelly, 2009). The recommended study could 
offer strategies to parents of students with MM treatment plans.  It could also be an 
outline for school district decision makers. This recommended future study could lead to 
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a comparative study of the process for obtaining MM policies. outlining the need for 
consistent school policies across states to ensure equitable practices for all students.   
Recommendation 2. According to these results future research should explore 
the rationale that causes school nurses’ resistance to administering medical marijuana in 
schools.  Brusie (2020) notes the law HB19-1028 which grants school nurses the 
permission to administer medical cannabis to students on school grounds in Colorado.  
The findings suggest school nurses may be hesitant to administer medical marijuana 
because the prescriptions lack recommended doses. Additional findings which are 
supported by the literature suggest nurses may be hesitant to administer medical 
marijuana because of moral convictions regarding children’s use of the drug (Kondrad & 
Reid, 2013).  A study to explore the perceptions of nurses regarding the administration of 
medical cannabis in schools would be beneficial to the progress of policy development.  
There is currently confusion regarding who is responsible for administering the medical 
marijuana treatment plan.  A study might resolve that issue and provide the perspectives 
of school nurses.  In all states, the federal law prohibits the possession and use of 
marijuana on school grounds (Pereira,at, el. 2020).  
The current policies in the school districts under study require parents to 
administer the MM treatment. The participants agreed that the current policies are 
inconvenient to the entire family. They also cause emotional and social stress for the 
children who feel isolated, singled out when their parents come to school daily. School 
nurse administration would allow students to feel a sense of normalcy and belonging. 
Under certain conditions, school nurses provide treatment for other children. Those can 
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receive their medication in the nurse’s office. The process is built into their daily school 
routine, limiting time out of class and instructional time lost.  
Recommendation 3. To ensure medical marijuana policies for all states are 
aligned, efforts must be directed towards revision of the existing federal laws that classify 
marijuana as a drug and prohibit the use and possession of the drug on school grounds. 
Some state laws permit the use of MM for recreation and medical purposes. Some states 
also permit the use of MM on school grounds as a treatment plan. To date the federal 
government has imposed any penalties on these states. This passive acceptance needs to 
be codified. 
Conclusion 
 Parents and school districts across the country face similar problems as more 
people turn to medical marijuana to treat their sick children, often after pharmaceutical 
remedies have failed (Norwood, 2018). The goal of this study focused on parent’s 
experiences with medical marijuana implementation policies in K-12 schools. The 
purpose of the study was to highlight the personal experiences, successes, and challenges 
faced by parents.  A qualitative narrative study design was used.  It included a three-
dimensional approach involving continuity (past. present, and future), situation (physical 
places), and interaction (personal and social). A narrative approach was used because it 
follows a chronology of events and situations. The researcher used semi-structured, open-
ended interview questions to collect data from participants. The participants included in 




A combination of various coding approaches was used to analyze, and cross-
analyze data. The analysis of the data collected from the interview question responses 
assisted in answering the research questions connected to the problem statement. In this 
study, the participants responded to three research questions that explored the experiences 
of parents who selected medical cannabis as a treatment plan and implemented a medical 
marijuana policy their child’s school. 
The lived experiences of these parents will contribute to the literature by focusing on the 
factors that impact the development and implementation of medical marijuana policies in K-12 
schools.  In most cases, medical marijuana is prescribed, and the dosage is suggested by doctors. 
Medical marijuana is commonly used in the form of an oil (cannabis oil), that the patient can ingest 
either through food or drink. The issue arises when students are prescribed a recommended dosage 
of medical marijuana that requires administration during the school day. Schools must comply with 
the federal and state laws to qualify for state and federal funding. The funding issues become 
complicated when the federal and state laws conflict. Public schools must make a choice in some 
cases: Do we support our students’ parents and provide the treatment plan of choice, or do we 
comply with federal funding regulations and limit the use of medical marijuana in our schools 
(Terrell, 2016)?  
New Jersey, Maryland, and Colorado are states that permit the administration of 
medical marijuana in its public schools. Governor Chris Christie’s bill A4587 was inspired by 
a parent from Maple Shade, New Jersey. This parent sought legal recourse to use cannabis 
treatment on school grounds after her request was denied by the school district (Livio, 2019). 
The bill was adopted in November 2015 making New Jersey one of the pioneer states 
permitting medical marijuana administration on school grounds.  A similar process was used in 
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both Maryland and Colorado to develop policies in public schools. This study provides an in-
depth understanding of the experiences of parents who collaborated with school districts to 
develop and implement medical marijuana policies.  
This study identified the adoption of state legislation as the key factor in 
achieving a medical cannabis policy in schools. It also discovered that parents selected 
medical marijuana as a treatment plan due to the adverse side effects of FDA approved 
medications. This study found that parents supporting other parents was an influential 
factor in the selection of a medical cannabis treatment. The parent online and in-person 
support afforded the study participants an opportunity to learn about the successes and 
challenges of trying to implement a medical cannabis policy in schools.  This study 
outlines the benefits of a thoughtful medical cannabis school policy. These include 
increased time in school for students, opportunity for data collections, improved 
academics, increased awareness by the board of education, and collaborative meetings. 
This study also detailed challenges presented by the current medical cannabis school 
polices. These include parents administering the treatment, lost instructional time, and 
social and emotional impacts on the children.  
The findings from this study, reinforce the need to incorporate the voice of 
parents in the development of medical cannabis administration school policies. A 
collaboratively developed policy would decrease some of the social and emotional stress 
children were experiencing and increase parental support and compliance. Additionally, 
there is need to understand why school nurses are opposed to administering medical 
cannabis to students. This disconnect between parents and school nurses can cause harm 
to medically fragile students. Also included in recommendations is a call for the 
 
95 
examination of the perspectives of urban parents. This study also cites the need to 
development consistent federal and state laws that can be the blueprint for medical 
cannabis policies in schools and ensure equity for all students regardless of financial 
status or resources. 
This research study is not only about parents’ experiences with the 
implementation of a medical marijuana policy. It is also about increasing awareness of 
medical marijuana as a treatment for students.  Medical marijuana is rapidly becoming 
legalized in the United States and parents who have had adverse effects with other 
treatments are selecting the treatment plan. The connections between parents and schools 
increase the likelihood of positive outcomes for students. Therefore, school policy 
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Official Letter of Invitation to Participate 
Study Title: Medical Marijuana in K-12 Public Schools: A Narrative Study of Parents’ 




 My name is Donise Robinson. I am a doctoral candidate in the Ed. D program in 
Executive Leadership at St. John Fisher College, Rochester, NY. I am currently 
employed as a Director of Special Education in a public-school district in New York.  I 
have a child who is diagnosed with epilepsy, ADHD and ODD. 
 As my dissertation research, I am exploring parents’ choice to use medical 
marijuana and or CBD as a treatment plan. I want to conduct interviews and learn about 
parents’ experiences with implementation of the treatment plans in K-12 public schools.    
 I am conducting this research study as part of the requirement of my doctoral 
degree in education, and I would like to invite you to participate. The participation in the 
study is voluntary. Involvement in the study would entail (a) answering the three 
qualifying questions (1-3 minutes); (b) Participation in a 45 to 60 minute interview. 
 All interviewees need to respond YES to the qualifying questions.  Additionally, 
they will need to allocate 2 sixty- minute blocks of uninterrupted time for the interview.  
This can be either by phone or virtual face to face and at an agreed upon time. The 
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interview will be audio recorded so that I can accurately reflect what is discussed. The 
audio will be reviewed by a hired confidential agency that will transcribe and analyze 
them and by me. They will then be destroyed after 3 years. If you feel uncomfortable 
answering some of the questions, you do not have to answer any questions that you do 
not wish to. Participation is confidential. 
 Your willingness to consider participation is greatly appreciated. As you know, 
minimal research has focused on the administration of medical marijuana in public 
schools.  Your participation in this study will benefit all schools as they develop their 
polices for treatment plans and encourage parents who are considering medical marijuana 
as a treatment plan. 
 Thank you for your consideration. For your convenience, I have listed the three 
qualifying questions below. If you can answer yes to these questions, you are eligible to 
participate. I have enclosed a reply form indicating your willingness to participate in the 
study. If you qualify and would like to participate, please sign the attached form, and 
return it to me at dr00208@sjfc.edu  
1. Do you have K-12 school-aged children?  
2. Do you have children who attend school in a state where medical 
marijuana/CDB is legal for medical treatment?   








To: Donise Robinson, Researcher 
From: 
I have received and read your invitation to participate voluntarily in your dissertation 
study regarding Medical Marijuana in K-12 Public School. A Narrative Study of Parents’ 
Experiences with Implementation. I have responded Yes to the qualifying question. 
 
My response is as follows: 
------------Yes, I will participate 






Informed Consent Form 
Title of Study: Medical Marijuana in K-12 Public Schools: A Narrative Study of 
Parents’ Experiences with Policy Implementation 
Name of Researcher: Donise Robinson 
Faculty Supervisor: Dr. William Jeff Wallis 
Phone for Further Information: 646-468-6817 
Purpose of Study: The purpose of this study is to examine the experiences of parents 
who choose medical marijuana as a treatment plan for their children and to examine the 
experiences of the parents with the implementation process of the plan in their children’s 
schools. 
Place of Study: virtually face to face or audio, at a mutually agreed upon time. 
Length of Participation: Approximately 90 minutes - two hours   
Method(s) of Data Collection: The interview questions will be distributed before the 
interviews. Interviews will be conducted and recorded digitally. 
Risk and benefits: Participation is voluntary. The expected risk and benefits of 
participation in this study are explained below:  
Minimal risk exists for most participants. Some participants may experience some 
emotional discomfort through recalling personal experiences about their children journey 
with health, academic and social issues. There is minimal to no risk of physical harm. 
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There is no benefit to the participant although the research will contribute to the 
conversations and research on medical marijuana and its benefits. 
Method for protecting confidentiality/privacy of subjects: Pseudonyms will be 
assigned to all participants. Participant names and any identifying information will 
remain confidential and not appear in transcripts or final study. Your information may be 
shared with appropriate governmental authorities ONLY if you or someone else is in 
danger, or if we are required to do so by law. 
Method for protecting confidentially/privacy of data collected:  
All digital audio recordings and transcriptions of the interviews will be 
maintained using a private, locked, and password-protected file and password-protected 
computer stored securely in the private home of the researcher. Electronic files will 
include assigned identity codes and pseudonyms; they will not include actual names or 
any information that could personally identify or connect the participants of this study to 
this study. Other materials, including notes or paper files related to data collection any 
analysis, will be stored securely in unmarked boxes, locked inside a closet in the private 
home of the researcher. Only the researcher will have access to the electronic or paper 
records. The digitally recorded audio data will be kept by the researcher for a period of 
5 years following publication of the dissertation. Signed informed consent documents 
will be kept for 5 years after publication of the dissertation. All paper records will be 
crosscut, shredded, and professionally delivered for incineration. Electronic records will 
be cleared, purged, and destroyed from the hard drive of the researcher, and all devices 




Your Rights: As a research participant, you have the right to: 
1. Know the purpose of the study and have the expected risks and benefits fully 
explained to you before you choose to participate. 
2. Withdraw from participation at any time without penalty. 
3. Refuse to answer a question without penalty. 
4. Be informed of the results of the study. 
5. Be informed of the appropriate policy development, if any, that might be 
advantageous to you. 
 
I have read the above, received a copy of this form, and I agree to participate in the 
above-named study. 
 
      
Print name (Participant) Signature Date 
 
 
      
Donise Robinson (Investigator) Signature Date 
 
If you have any further questions regarding this study, please contact the researcher listed 
above. If you experience emotional or physical discomfort due to participating in this 
study, please contact your personal health care provider or an appropriate crisis service 
provider. The Institutional Review Board (IRB) of St. John Fisher College will review 
this project. For any concerns regarding this study, or if you feel that your rights as a 
participant (or the rights of another participant) have been violated or caused you undue 
distress (Physical or emotional distress), please contact irb@sjfc.edu. A supervisory IRB 




Appendix C  
Interview Questions 
Research Questions Interview Questions 
1.Given current medical 
marijuana policies, how do 
parents describe their 
experiences implementing 
their children’s treatment 
plan? 
Why did you choose medical marijuana as a treatment plan for your 
child? 
 
How did your child’s school personnel react to your choice to use 
medical marijuana as a treatment plan? 
 
What, if any, positive and or negative experiences did you have while 
collaborating with the school to implement your child’s treatment 
plan? 
 
Can you share an experience during the process that left you feeling 
confident about your decision? 
 
Can you share an experience during the process that left you feeling 
doubtful about your decision? 
How does medical 
marijuana impact parent’s 
perceptions of their child’s 





Have you had to postpone your preferred treatment plan of medical 




How did this shape your child’s academic performance? 
 
Do you view the current medical marijuana polices to be effective for 
children in K-12 schools? 
 
Have your child’s data on report cards increased or decreased due to 
the MM policy? 
 
Was there an improvement in academic outcomes due to 
implementation of MM policy? 
 
Can you share a moment or memory that stands out for you regarding 
your child’s academic experience before or after implementation of the 
policy? 




policy on their 





Has your child experienced any barriers in social development in 
school? 
 
Have behavioral concerns increased or decreased due MM policy? 
 
Do you feel your child’s social development has improved or declined 














Do you feel your voice has been heard in the process regarding your 
child’s social development? 
 
What would you say to someone considering this treatment plan and 
journey with a school district?  
 
How has the choice of MM as a treatment plan affected your child’s 
emotional state? 
 
Can you share any success of challenges of your child’s emotional 
development due to the policy? 
 
Can you share an experience made you   reconsider your treatment 
plan because of your child’s emotional development? 
 
Has your child made emotional improvements that can be contributed 
to MM policy? 
 
 
 
  
 
 
